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ABSTRACT 
PARTICLE ENGINEERING VIA SURFACE MODIFICATION DURING 
MICRONIZATION FOR PHARMACEUTICAL APPLICATIONS 
by 
Xi Han 
Improving the dissolution rate of Biopharmaceutics Classification System (BCS) class II 
drugs is an important research area. Micronization which can increase the specific surface 
area is a promising method to improve the dissolution rate. Micronization alone, 
however, can lead to downstream processing problems related to poor flow and 
dispersion properties. The importance of the flowability of pharmaceutical powders is 
well-documented in the literature. It is, therefore, important to develop a method that can 
simultaneously overcome these processing issues and allow for micronizing the API. In 
this work, dry particle coating technique is investigated in the context of micronizing API 
powders and overcoming problems associated with the micronized fine powders due to 
their strong cohesive forces. Consequently, the main objective of this dissertation is to 
investigate if simultaneous micronization and dry coating process (SM-DC) is beneficial 
for pharmaceutical applications. The work addresses and answers several important 
issues as discussed next.  
First, using ibuprofen as a test-case, it is shown that flow properties and 
dissolution rate were significantly improved when micronization was performed along 
with dry coating (SM-DC process). Additionally, co-grinding with water-soluble polymer 
during micronization was considered and led to further dissolution rate improvement and 
increased bulk density. The surface modified, micronized powders also showed improved 
dispersion, significantly higher bulk densities, reduced electrostatic charging, and higher 
flowability compared to the pure micronized sample. Next, these dry coated fine API 
ii 
 
powders were formulated into blends with different API loadings. The results showed 
that the blends containing dry coated API powders had excellent flowability and high 
bulk density. In contrast, blends containing uncoated APIs had poor flow and lower bulk 
densities. As the API loading increased, the difference between dry coated and uncoated 
blends was more pronounced. Tablets prepared from dry coated API blends exhibited 
superior compactibility and dissolution profiles, particularly for higher drug loadings. 
This illustrated the advantages of the dry coating during API micronization, without any 
adverse impact on tabletting operations and tablet properties. Next, an in-depth 
understanding of the effect of milling and dry coating on the surface properties of milled 
ibuprofen powders was investigated. Inverse Gas Chromatography technique was used 
and the dispersive surface energy of pure milled powders was heterogeneous in nature. In 
contrast, dry coating with nano-particles was found to quench the high energy sites and 
make the surface energy of the powders comparatively uniform and the average values 
similar to that of the nano-particle used for the dry coating. Last, a simple shear test based 
method was developed to estimate the granular Bond number to evaluate the performance 
of dry coating. This technique eliminates the usual need of detailed, time consuming 
particle scale characterization via atomic force microscopy. Estimated Bond numbers 
were compared and verified with those calculated from IGC method. Further, estimated 
Bond number was correlated with the bulk flow properties. The overall effect of dry 
coating (changing both the surface energy and nano-scale asperities) can be well 
demonstrated using the estimated Bond numbers. By addressing these four issues, the 
main hypothesis of the thesis, dry coating applied to the micronization process is 
beneficial to the pharmaceutical application, is proven.  
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 CHAPTER 1 
BACKGROUND AND OBJECTIVE 
 
1.1 Poorly Water Soluble Drugs 
The Biopharmaceutics Classification System (BCS) has classified class II drugs as poorly 
water-soluble and high intestinal permeability. This indicates that their bioavailability is 
strongly controlled by their dissolution rate [1]. Since nearly 40% of all active 
pharmaceutical ingredients (APIs) being developed in the pharmaceutical industry are 
poorly water-soluble [2], improving the dissolution rate of poorly water soluble drugs is 
an important research area. Particle size reduction, discussed next, is the main focus of 
this work, in particular, dry powder micronization. 
 
1.2 Particle Size Reduction 
Particle size reduction that can increase the specific surface area, and is a promising 
method to improve the dissolution rate [3-6], as suggested by the Noyes-Whitney 
equation [7]. Methods for reducing particle size can be broadly classified into two 
approaches: (i) bottom-up and (ii) top-down. Bottom-up approaches start with drug 
molecules in solution. By changing the conditions of the system in solution, the drug 
molecules start to precipitate in larger formations [8, 9]. The application of bottom-up 
approach is less favorable in pharmaceutical industry as it may be expensive, involves 
organic solvents and stabilizer [3], requires further processing steps to form dry powders 
[4] and may generate unstable amorphous state of active pharmaceutical ingredient [10]. 
In contrast to the bottom-up approaches, one can also start with large API particles and 
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break them down to small drug particles down to less than 10 microns or even to 
nanoparticles. Currently particle size reduction technologies of this type are by far 
commercially the most important and successful. Bottom down approaches include wet 
ball milling [3, 11], micronization utilizing jet mill [12]. The jet milling method is widely 
applied to a variety of poorly soluble drugs [4] especially for producing APIs for 
inhalation application [13]. It uses the energy of the fluid (high pressure air) to achieve 
the required grinding. Jet milling is a dry process with no moving parts, which does not 
require any solvent and potentially can have minimal contamination. The process is also 
suitable for heat sensitive drugs and it is capable of manufacturing large quantities of 
powder.  
Simple micronization, however, will not always result in an increase in surface 
area and expected improvement in dissolution rate. The high cohesion arising from strong 
van der Walls force [14] between micronized powders, results in the tendency for these 
particles to agglomerate [3, 15, 16]. This subsequently gives rise to poor flowability, low 
bulk density and may lead to an increased tendency for these particles to get 
electrostatically charged. These undesired properties are likely to affect downstream 
powder processing and handling during unit operations. Subsequently, extra processing 
steps such as granulation may be required to increase the bulk density and flow. It can 
also lead to a significant loss of revenue due to non-uniformity of drug content in the 
final product [17]. Thus there is a significant motivation for developing approaches that 
improve the flow of fine powders obtained from micronization. 
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1.3 Powder flowability 
A simple definition of powder flowability is the ability of a powder to flow.  However, 
powder flow is a complex problem and depends on many characteristics. Powder 
flowability is the results of the combination of material physical properties that affect 
material flow and the equipment used for handling, storing or processing the material. 
 Sufficient powder flow is required in order to be able to produce high-quality 
solid dosage forms [18, 19]. The ease of flow is recognized as the key property in powder 
handling since mixing and transportation are the basic requirements for industries. For 
example, in [20], a guideline for the powder flowability for high speed tabletting process 
indicates: “Avicel PH102 exhibits borderline flow properties for high speed tabletting. A 
powder exhibiting poorer flow properties than Avicel PH102 likely exhibits flow 
problems and should be avoided.” For reference, Avicel PH102 has a flow function 
coefficient (FFC, defined later in chapter 2) value of 6.7 (under 9 kPa consolidation 
stress). Jenike classified powder flow behavior according to the FFC value [21]: i.e., FFC 
< 1, not flowing; 1 < FFC < 2, very cohesive; 2 < FFC < 4, cohesive; 4 < FFC < 10, easy 
flowing, and FFC > 10, free-flowing. 
 
1.4.Inter-particle forces 
The dominant inter-particle force over gravitational force and friction force contributed to 
the poor flowability of fine powders [14]. Van der Waals force is the main component of 
inter-particle force for dry neutral and inert particles. The inter-particular force depends 
on many factors, e.g., particle size, particle shape, surface roughness, surface energy, 
material hardness and elasticity, and deformation of the materials [22]. Among of those, 
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surface roughness and area of contact are the two most important factors. The measured 
adhesion force of particles (10-100 μm) is found to be always less than the theoretical 
values [23]. This is because real materials always have some degree of roughness. 
Roughness in nano or submicron scale can significantly decrease the true area of contact  
[24]. The area of contact is another important factor. Larger contact area requires more 
energy to create new surfaces or separate two surfaces.  
Many models have been developed to predict the adhesion force of cohesive 
powders by calculating the pull-off force which is the maximum forces needed to 
separate two contact surfaces. In the following, several inter-particular force models will 
be discussed. These models consider either one or more key factors that affect the inter-
particle adhesion force.  
(1). Rumpf model describes the adhesion between a sphere and a flat rough 
surface. A hemi-sphere is centered on the flat surface to represent as a single asperity [25] 
(Figure 1.1). The Rumpf model is shown in Equation 1.1. The first term on the right side 
of the equation represents the interaction between the large sphere in contact with the 
asperity and the second describes the “noncontact” interaction between the large sphere 
and the flat surface [26]. Here, A is the Hamaker Constant, z0= 4×10
-10
 m is the distance 
between two contact surfaces, d and D are the diameters for the semispherical asperity 
and the large sphere.  
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0 012 (1 / 2 )
vdw
A dD D
F
z d D d z
 
  
  
 (1.1) 
   
5 
 
 
 
 
Figure 1.1 Schematic illustration of the Rumpf model [26]. 
 
(2). Johnson et al [27] took into account of contact deformation between two 
elastic smooth spheres. The authors derived an Johnson-Kandall-Roberts (JKR) adhesion 
force model (Equation 1.2) including the elastic contact deformation by assuming that the 
contact stress is compressive in the center of contact area while at the edge of the contact 
area contact stress is tensile.  
 
 
*3
2
adF R  (1.2) 
 
In Equation 1.2, * 1 2
1 2
R R
R
R R


 is the characteristic radius; R1 and R2 are the radius 
of contact spheres.  is the work of adhesion between the contacted surfaces and can be 
calculated by: 
  
 1 2 12        (1.3) 
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Where 
1 and 2 are the surface free energies of each surface and 
12 1 2 1 22        is the interfacial energy. 
(3). Derjaguin et al [28] developed a Derjaguin-Muller-Toporov (DMT) model to 
calculate the adhesion force between two surfaces in contact based on a different contact 
stress assumption compared to the JKR model. It assumes that the compressive stress is 
in the whole contact area and tensile stress is out of the contact area. The DMT model is:  
  
  
 
*2adF R    (1.4) 
         
(4). Chen’s advanced model. Models described above (1)-(3) either only consider 
the effect of a single asperity located in between or only consider the effect of contact 
area on the adhesion force. The combination of these two key factors and the effect of 
surface area coverage of the small particles on the large particles are not considered in 
models (1)-(3). In Chen’s advanced model [29], the influence of surface area coverage, 
the effect of inter-particle compressive force and contact deformation under small 
consolidation are considered. Model for dense coating is shown below, Equations 1.6-1.9. 
Here, λ is the Tabor parameter, Δ is the work of adhesion between two solid surfaces, Rp 
is the effective contact radius, 
1
2 2
* 1 2
1 2
1 1
E
E E
 

  
  
 
is the reduced Young’s module, H 
is the hardness of the soft material and Fon is the compressive force applied on the 
surfaces in contact and SAC is the surface area coverage. 
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 pull off pF R     (1.5) 
 
 
* 1/2
3/2( )
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p
E F
R
H


  (1.6) 
 
 
*cos 2
3
on
c
F
F R      (1.7) 
 
 
0.302
cos 1
SAC
    (1.8) 
 
1.5 Dry Particle Coating 
Common approaches to overcome poor flow properties are particle size enlargement by 
granulation. Flow properties can also be affected by formulation design; for instance 
increasing the amount of excipients in a blend can improve the powder flow. Also 
polymer thin film coatings have been used to improve powder flow [30]. However these 
methods require either solvents and/or multiple processing steps and long processing time 
Surface modification via dry coating nano-particles (Figure 1.2) is an effective 
and simple method to improve the flowability of powders [31, 32]. In dry particle coating, 
ultra-fine guest particles are uniformly dispersed over the surface of host or carrier 
particles in order to enhance the property of the host material, most common example 
being its flow. Although flow enhancement can be easily obtained through blending with 
flow additives, it has been shown that dry coating devices [33], which involve high level 
of impacts and/or shear, lead to uniform dispersion of guest nano-particles rather than 
sparse, inefficient coating expected when flow additives are blended using conventional 
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mixers [32]. Various host materials including pharmaceutical powders (excipients and 
APIs), and different types of guest materials (silica, alumina, titania, talc, MgSt, leucine, 
carbon black, etc.) have been considered. Enhanced powder properties such as flowability, 
bulk density, reduced electrostatics, and dispersibility, were obtained compared to both 
uncoated powders and powders simply blended with the guest material in a conventional 
mixer [31-35]. Main mechanisms of flow enhancement through dry coating have also 
been investigated. It has been shown using a single asperity model validated by 
experiments that (a) flow improvement is due to the cohesion that is reduced due to 
decreased van der Waal’s attraction between two host particles, and (b) cohesion 
reduction is inversely proportional to the guest particle size [32].  An advanced multiple-
asperity model taking into account the effect of the surface area coverage (SAC) of the 
coated nano-sized particles has also been developed to better predict the effect of dry 
coating on the cohesion reduction [29]. In that study, it was shown that a minimum SAC 
of at least 20 %, and more preferably, about 40 % is required to eliminate host-host and 
host-guest contacts [36]. It was also shown that that optimal guest size is in the range of 
10-20 nm, and the SAC should not be over 100 % for ensuring optimal level of cohesion 
reduction. Overall, such models show that the presence of nano-sized guest particles can 
influence both the surface roughness (modifies the contact radius and area between 
particles) and the surface energy (modifies the strength of interaction), which will reduce 
the cohesive force among the coated particles and ultimately improve the bulk powder 
behavior [29, 32, 34, 36-38].   
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Figure 1.2 Schematic illustration of dry coating process. 
 
1.6 Dry Coating Equipment 
Based on the particle size, there are two different approaches for dry coating (Ghoroi et 
al., 2012b; Ghoroi et al., 2012a). The first approach is usually for particles > 25 µm 
employing a Magnetically Assisted Impaction Coater (MAIC) (Figure 1.3 a) or a 
continuously operating cone-mill, (Figure 1.3 b) or hereafter called comil (Beach, 2011), 
where attrition of particle size is kept to a minimum. The second approach, where 
simultaneous micronization and surface modification is employed using a fluid energy 
mill (FEM, Figure 1.3 c), is suitable for finer particles (< 25 µm) including those used in 
the inhalation application (~ 2 to 5 µm), where materials such as amino acid instead of 
nano-silica are used for dry coating (Ghoroi et al., 2012a; Ghoroi et al., 2012b).  
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Figure 1.3 Schematic illustrations of (a) Magnetically Assisted Impaction Coater 
(MAIC), (b) comil, http://www.quadrocomil.com/products_comil_lab.asp and (c) fluid 
energy mill (FEM), http://sturtevantinc.com/micronizer.php 
1.7 Objective 
Based on the above discussion, it is beneficial and important to develop a method that can 
simultaneously micronize the API powders and overcome typical processing issues. 
Since dry particle coating technique has been shown to be an effective and simple method 
for improving the flowability of the powders, it should be applied to the pharmaceutical 
materials especially for the fine or micronized API powders. It is therefore very 
interesting to investigate whether a method associated with dry coating technique can be 
developed to micronize API powders and overcome issues of micronized fine powders 
due to their strong cohesive forces. More specifically, our hypothesis is that simultaneous 
micronization and dry coating process (SM-DC) would be beneficial for pharmaceutical 
(a) (b) 
(c) 
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application. In order to prove this, several important issues need to be fully addressed. 
Consequently, this work will answer questions such as: Is SM-DC process feasible for 
pharmaceutical powders? Is SM-DC process still beneficial when SM-DC API powders 
are formulated into blends and compacted into tablets? What is the role of dry coating in 
improving the flow of the micronized powders? In order to assess the impact of SM-DC 
on particle scale properties, how useful is the granular Bond number and is there a way to 
easily estimate it without using atomic force microscopy (AFM) for dry coated powders 
and use it to estimate the improvement in powder flow? This thesis addresses all these 
questions as outlined below. 
 
1.8 Dissertation Outline 
First (Chapter 2), using ibuprofen as a test-case, it is shown that flow properties and 
dissolution rate were significantly improved when micronization was performed along 
with dry coating (SM-DC process). Additionally, co-grinding with water-soluble polymer 
during micronization was considered and led to further dissolution rate improvement and 
increased bulk density. The surface modified, micronized powders also showed improved 
dispersion, significantly higher bulk densities, reduced electrostatic charging, and higher 
flowability compared to the pure micronized sample. Next, (Chapter 3) these dry coated 
fine API powders were formulated into blends with different drug loadings. The results 
showed that the blends containing dry coated API powders, even micronized ones, had 
excellent flowability and high bulk density. In contrast, blends containing uncoated APIs 
had poor flow and lower bulk densities. As the drug loading increased, the difference 
between dry coated and uncoated blends was more pronounced, which was clearly 
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illustrated through a bulk density-FFC (flow function coefficient) phase map. Tablets 
prepared from dry coated API blends exhibited superior compactibility and dissolution 
profiles, particularly for higher drug loadings. This illustrated the advantages of the dry 
coating during API micronization, without any adverse impact on tableting operations 
and tablet properties. Next, an in-depth understanding (Chapter 4) of the effect of milling 
and dry coating on the surface properties of milled ibuprofen powders was investigated. 
Inverse Gas Chromatography (IGC) technique was used and it was shown that the 
dispersive surface energy of pure milled powders is heterogeneous in nature. In contrast, 
dry coating with nano-particles was found to quench the high energy sites and make the 
surface energy of the powders comparatively uniform and the average values similar to 
that of the nano-particle used for the dry coating. Last (Chapter 5), a simple shear test 
based method was developed to estimate the granular Bond number to evaluate the 
performance of dry coating. This technique is very important for industry because it 
eliminates the usual need of detailed, time consuming particle scale characterization via 
atomic force microscopy (AFM), which would be otherwise necessary. Estimated Bond 
numbers were compared and verified with those calculated from IGC method. Further, 
estimated Bond number was correlated with the bulk flow properties. The overall effect 
of dry coating (changing both the surface energy and nano-scale asperities) can be well 
demonstrated using the estimated Bond numbers. By addressing these four issues, the 
main hypothesis of the thesis, dry coating applied to the micronization process is 
beneficial to the pharmaceutical application, is proven. 
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CHAPTER 2 
SIMULTANEOUS MICRONIZATION AND SURFACE MODIFICATION FOR 
IMPROVEMENT OF FLOW AND DISSOLUTION OF DRUG PARTICLES  
2.1 Introduction 
The Biopharmaceutics Classification System (BCS) has classified class II drugs as both 
poorly water-soluble and high intestinal permeable, indicating that their bioavailability is 
strongly controlled by their dissolution rate [1]. Since nearly 40% of all drugs being 
developed in the pharmaceutical industry are poorly water-soluble [2, 6], improving the 
dissolution rate of poorly water-soluble drugs is an important research area. It is well 
recognized that micronization that can increase the specific surface area, is a promising 
method to improve the dissolution rate [3-6], as suggested by the Noyes-Whitney 
equation [7]. Micronization alone, however, can lead to downstream processing problems 
related to their poor flow and dispersion properties. It is therefore important to develop a 
method that can simultaneously overcome these processing issues and micronize the drug 
particles. Although there are several top-down approaches, such as slurry mill or ball mill 
[39], in this paper, micronization of poorly soluble drugs utilizing jet mill [4, 12] is 
considered. Jet milling uses the energy of the fluid (high pressure air) to achieve the 
required grinding, thus it is a dry process with no moving parts, and does not require any 
solvent and potentially can have minimal contamination. The process is also suitable for 
heat sensitive drugs and it is capable of manufacturing large quantities of powder in 
continuous fashion. 
Simple micronization, however, will not always result in an increase in surface 
area and the expected improvement in dissolution rate. The high cohesion of micronized 
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powders [14] results in the tendency for these particles to agglomerate [3, 15, 16]. This 
subsequently gives rise to poor flowability, low bulk density and may lead to an 
increased tendency for electrostatic charging and thus adversely affecting downstream 
processing and handling. It can also lead to a significant loss of revenue due to non-
uniformity of drug content in the final product [17]. Subsequently, extra processing steps 
such as granulation may be required. Thus there is a significant motivation for developing 
approaches that improve the flow of fine powders obtained from micronization. 
The importance of the flowability of pharmaceutical powders is well-documented 
[18, 19]. Many methods to improve the flowability of cohesive powders are based on 
controlled agglomeration or by coating of polymer films [40, 41]. A recent method that is 
effective and simple for improving the flowability of powders [31, 32] is based on 
surface modification via dry coating, where the surface of the cohesive drug particles 
(host) is coated with small amount of nano-sized particles (guest). It has been also shown 
that cohesion is reduced due to the creation of nano-scale surface roughness [32, 34, 42], 
making this approach useful for present topic. Accordingly, simultaneous micronization 
and surface modification of drug particles is considered in order to improve the 
dissolution rate of poorly water-soluble drugs, while eliminating typical disadvantages of 
the simple micronization process such as, agglomeration, poor flowability, loss of 
expected large surface area and low bulk density. In the proposed process, a continuous 
fluid energy mill (FEM) is used where larger drug particles pre-blended with nano-silica 
are micronized to achieve fine surface modified drug particles via dry-coating of nano-
silica, This was first suggested in [43], where non-pharmaceutical powders were shown 
to have improved flow due to surface coating with nano-silica. While it is expected that 
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improved dispersion or reduced agglomeration after surface modification during 
micronization, may lead to improved dissolution, it could be further enhanced by co-
grinding with water-soluble polymers in the FEM with a hope of imparting improved 
surface wettability. Generally large quantities of water-soluble excipients such as 
polymers and sugars are employed as solid dispersion excipients [44-46], where drugs 
may typically attain amorphous content due to high mechanical energy co-grinding using 
ball-mills. In contrast, our study employs small amount of Polyvinylpyrrolidone (PVP) as 
co-grinding excipient, while nano-silica is added to enhance flow. It is hoped that PVP 
will impart improved wettability to drug powders, at the same time, using FEM that has 
significantly lower mechanical stresses and orders of magnitude shorter 
processing/residence time will not affect the crystalline form of the drug considered, and 
thus would be favorable in terms of physical stability of the drug [4]. 
Ibuprofen, one of the widely used analgesic or anti-inflammatory drugs, is 
selected as a model poorly water-soluble BCS class II drug. Aqueous solubility of 
ibuprofen (molecular weight 206.28 g/mol) is very low (0.056±0.004 mg/ml [47], 0.09 
mg/ml [48] and 0.081mg/ml [49]). In this paper, micronization of ibuprofen in the FEM 
along with dry coating using nano-silica with or without co-grinding with PVP was 
carried out in order to investigate if it leads to improved dissolution along with increase 
in flowability and bulk density, as compared to uncoated micronized ibuprofen powder.  
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2.2 Experimental 
 
2.2.1 Materials 
Ibuprofen 110 was purchased from Alfa Chem, (NY, USA), having volume median 
particle size (d50) of 102 m, and volume mean particle size (d [4, 3]) of 123 m. Although 
as received ibuprofen has relatively large size, it is found to be cohesive in nature, has 
poor flowability and difficult to feed through a volumetric feeder. Pharmaceutical grade 
amorphous hydrophilic silica (M-5P type, primary particle size of 15 nm) was received as 
a gift from Cabot Corporation (MA, USA). PVP 40 (average mol wt 40,000, median 
particle size 95 m), monosodium phosphate, sodium dodecyl sulfate and disodium 
phosphate were purchased from Sigma-Aldrich Inc., USA. All other chemicals used were 
analytical grade.  
2.2.2  Preparation of FEM Processed Samples 
(a) Pre-mixing of powders in V-blender 
Pre-mixing of powders was performed in a 6-quart V-shaped blender (BlendMaster, 
Patterson-Kelley, PA, USA) with intensifier bar (also called as agitator bar or internal 
stirring bar). The tip of the intensifier bar extends 55 mm from the rotational axis. The V-
blender was operated at 25 rpm whereas the intensifier bar was rotated at 3600 rpm to 
enhance the mixing inside the shell. Three types of pre-mixed powders were prepared: (1) 
ibuprofen (500 g) pre-mixed with silica (varied from 0.5wt% to 5.0 wt%). It was first 
processed in the V-blender for 10 min with intensifier bar and followed by 20 min 
without intensifier bar (2) ibuprofen pre-mixed with silica (400 g) and PVP (100 g) was 
processed for 5 min. And (3) ibuprofen (400 g) and PVP (100 g) was processed for 5 min. 
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There was no pre-mixing step for simple micronization of ibuprofen without any dry 
coating. For the experiments to study the effect of nano-silica content on flowability, the 
amount of nano-silica was varied from 0% to 5.0%.  
(b) Processing in fluid energy mill (FEM) 
Pre-mixed powders were processed in a qualification FEM unit (Sturtevant Inc., MA, 
USA). Solid feeding rate (SFR) was controlled by a volumetric feeder (Schenck Accurate 
WI, USA) and was calibrated using the pre-mixed powder before each experiment. 
Figure 2.1 illustrates the experimental setup and methodology. A similar procedure was 
followed for pure micronized powder (without any dry coating). Processed powder was 
then stored in vacuum desiccators for subsequent flow characterization and dissolution 
test. Based on the preliminary experimental observation and pervious results [43, 50], 
experiments were performed at a constant feeding pressure (FP) of 30 psi. While grinding 
pressure (GP) was varied from 10 psi to 30 psi, and SFR was varied from 1.0 g/min to 
10.0 g/min. List of experiments is given in Table 2.1. From these experiments, two 
typical samples with different sizes (d50 are 5 microns and 10 microns) were selected for 
further study (Table 2.2). Co-grinding with PVP experiment was carried out only for 10 
microns particles using the similar processing condition mentioned for 10 micron 
particles.  For those uncoated samples UC-IBU-5, UC-IBU-10 and UC-IBU-PVP-10, due 
to their cohesivity, it was difficult to control the solid feed rate and hence multiple 
experimental runs were required to collect required size samples. 
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Table 2.1. List of Experiment for Studying the Effect of FEM Operating Conditions on 
Particle Size 
 
span = [(d90 - d10)/d50] 
  
Serial 
# 
Experiment code Material FP 
(psi) 
GP 
(psi) 
SFR 
(g/min) 
d50 
(µm) 
span 
1 FEM-GP10-SFR1  
 
Ibuprofen 
pre-mixed 
with 1.0 
wt% of 
nano-silica  
30 10 1.0 3.6 1.4 
2 FEM-GP10-SFR5 30 10 5.0 9.1 2.0 
3 FEM-GP10-SFR10 30 10 10.0 16.8 2.1 
4 FEM-GP20-SFR 1 30 20 1.0 2.3 1.3 
5 FEM-GP20-SFR5 30 20 5.0 5.4 1.7 
6 FEM-GP20-SFR10 30 20 10.0 8.3 1.9 
7 FEM-GP30-SFR1 30 30 1.0 1.7 1.3 
8 FEM-GP30-SFR5 30 30 5.0 3.4 1.5 
9 FEM-GP30-SFR10 30 30 10.0 5.1 1.7 
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Table 2.2 
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Figure 2.1 Schematic illustration of the experimental setup and methodology, 
http://sturtevantinc.com/micronizer.php, http://en.wikipedia.org/wiki/File:V-Blender-
Logo.gif. 
 
2.2.3 Powder Characterization 
(a) Particle size measurement 
Particle size distribution of powders was measured via the laser diffraction technique 
(Rodos/Helos system, Sympatec, NJ, USA) where the d10, d50, d90 and d[4,3] size 
statistics are reported. In addition, pressure titration tests were also performed by a series 
of repeat measurements at different dispersion pressure (0.2 bar to 2.0 bar). Values of d90 
and d50 versus dispersion pressure were plotted to infer the dispersibility of the powder.  
Generally, the dispersibility of the powder is significantly impacted by the particle size 
and size distribution given that other particulate properties are similar. All FEM 
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processed powders were tested twice using the Rodos/Helos system to characterize their 
dispersibility.  
(b) Scanning Electron Microscope (SEM) 
The morphology of particles was examined using a Field Emission scanning electron 
microscope (FESEM) (LEO 1530 170, Carl Zeiss SMT Inc., MA, USA)  All powder 
samples were pre-coated with carbon using a sputter coater to enhance conductivity under 
FESEM. 
(c)  Angle of repose test 
Angle of repose (AOR) is the internal angle between the surface of a pile of powders and 
the horizontal surface. According to the United Stated of Pharmacopeia (USP), AOR 
measurement is one of the four conventional methods for characterizing powder flow and 
is the easiest and most commonly used method [51-53]. AOR measurement, performed in 
the Hosokawa powder tester (Model PT-N, Hosokawa Micron Powder System Co., NJ, 
USA), is a technique that combines both static and dynamic powder states: powder was 
allowed to flow through a funnel in and fall onto a flat surface. Carr classified the 
powders according to the AOR, AOR in the range of 25–35° indicates excellent 
flowability, AOR less than 40° is considered to be acceptable and AOR greater than 45° 
is considered to be cohesive [54]. AOR measurements were performed according to the 
standard ASTM D6393-08, “Bulk solids Characterization by CARR Indices”. Each 
measurement was repeated at least 4 times and average values are reported. 
(d) Powder characterization using FT4 powder rheometer 
Powder properties were also characterized using a powder rheometer [55, 56]. In this 
work, a Freeman FT4 powder rheometer with a shear cell module (Freeman Technology 
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Ltd, Worcestershire, UK) was utilized for the following three tests to characterize the 
rheological and shear properties of different processed and unprocessed powders: (1) 
conditioned bulk density test, (2) compressibility test and (3) shear cell test. Detailed 
experimental procedure is described in elsewhere [57]. All the powder samples were 
tested twice and average values are reported.  
Before each measurement, powder sample was conditioned to ensure 
reproducibility of the testing. During condition, the energy required to move the blade 
was measured as specific energy (SE). In general, the higher the SE, the more cohesive 
the powder is [57]. Typically, for SE<5, powder has low cohesion; for 5<SE<10, powder 
has moderate cohesion; for SE>10, powder has high cohesion
1
. 
Compressibility of powder sample was determined by measuring the volume (or 
density) change of the powder sample as a function of applied normal stress. 
Conditioning blade was replaced by a vented porous piston which was programmed to 
apply 1, 2, 4, 6, 8, 10, 12 and 15 kPa normal stresses across the whole cross section of the 
vessel.  
The shear cell module of FT4 is designed to measure shear stress at different 
normal stresses applied on the powder, which is pre-consolidated at a particular pressure. 
Based on the recommendation of ASTM standard for powders having low density [58] 
and the range of consolidation stresses normally encountered by pharmaceutical powders, 
a 3 kPa pre-consolidation load was chosen. A Mohr’s diagram was constructed using the 
FT4 software and several parameters were obtained from the Mohr’s diagram. These are 
maximum principle stress (σ1), the unconfined yield stress (σc), the flow function 
                                                             
1
 From FT4 manual 
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coefficient (FFC) and cohesion. FFC, which is the ratio of maximum principle stress to 
the unconfined yield stress, is the most commonly used parameter for powder flow 
characterization [59, 60]. A classification of powder flow behavior similar to that by 
Jenike [21] has been defined by Schulze according to the FFC value: i.e., FFC < 1, not 
flowing; 1 < FFC < 2, very cohesive; 2 < FFC < 4, cohesive; 4 < FFC < 10, easy flowing, 
and FFC > 10, free-flowing [59].  
(e) X-ray powder analysis (XRD) 
Most of the pharmaceutical products contain drug in the crystalline form due to its greater 
stability. Normally the crystalline form is examined using X-Ray powder diffraction 
(XRD). In this work, XRD was performed using Siemens Philips PW3040 X-ray 
diffractometer (MA, USA) using Cu as a target at a voltage of 45 kV and current of 40 
mA. Samples were scanned for a 2θ range of 5-45° at 1° (2θ)/min by a Cu_K radiation 
source of wavelength 1.542 A°. Diffraction pattern of the powders were compared with 
the standard XRD database. 
(f) Raman spectroscopy 
Raman spectroscopy as an additional technique was applied to test the crystallinity of the 
samples. EZRaman LE Raman Analyzer System (Enwave Optronics, Inc., CA, USA) 
coupled to MicroView adapter with a 4x objectives, 15 µm spot size, 250mW 785 nm 
excitation laser was used to scan the samples. Each sample measurement corresponded to 
an average of 2 scans, each 10 seconds long, totaling 20 seconds in scanning time.   
(g) Differential scanning calorimeter (DSC) 
Differential scanning calorimetry was performed using DSC Q100 analyzer (TA 
Universal Instruments, DE, USA) equipped with a refrigerated cooling system. The 
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chamber was flushed with N2 at a flow rate of 40 ml/min during the test. About 3 mg of 
sample was heated in an aluminum pan from 35 
°
C to 90 
°
C at a constant heating rate of 
10 °C/min. The DSC data were analyzed by using Universal Analysis 2000 software. The 
heat of fusion was calculated [61] from the peak area of thermogram corresponds to 
melting point of ibuprofen. The crystallinity (Xcr) was calculated according to the 
following Eq. (2.1). Silica content was ignored because of small amount used (1.0 wt%). 
 
 
0
100%cr
HX
H
   (2.1) 
 
Where H0 and H are the heat of fusion of the original crystals and the micronized 
crystals respectively. Samples were tested twice and average values are reported.  
(h) Surface are measurement 
The Brunauer–Emmett–Teller surface areas of the samples were measured using a 
nitrogen adsorption instrument NOVA 3200 (Quantachrome instruments, FL, USA), 
using a standard protocol. Before testing, each sample with known weight was degassed 
overnight at room temperature under vacuum to remove adsorbed gases and nitrogen was 
used as adsorbent gas. Samples were tested twice and average values are reported. 
(i) Electrostatic measurement 
The electrostatic charge accumulated by the powders during FEM processing was 
measured by utilizing a Nanocoulombmeter equipped with a Faraday Cup (Model 230, 
Electro-Tech Systems, Inc, PA, USA). For each measurement, certain amount of powder, 
collected fresh after FEM processing, was gently placed into the faraday cup. The charge 
was transferred to the cup and measured by the Nanocoulombmeter. Test was performed 
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in a temperature and humidity controlled environment. For each powder, at least three 
measurements of each sample were performed and average value was reported. 
2.2.4 Powder Dissolution Test 
Dissolution studies were performed according to the USP 30 dissolution procedure for 
apparatus 1 [62] using a Distek 2100A dissolution apparatus (Distek Inc., NJ, USA) with 
a temperature control system (TCS 0200). The dissolution medium (900 ml) was 
phosphate buffer solution (pH= 7.2) with 50 mg sodium dodecyl sulfate (SDS). The 
basket rotating speed was 50 rpm, and the temperature was maintained at 37 °C ± 0.2 °C. 
Powder samples equivalent to 200 mg of ibuprofen were added to the dissolution 
apparatus for dissolution test. Liquid medium was collected at pre-determined time 
intervals, and filtered through a 0.45 µm filter for further quantitative test. Quantitative 
test of dissolved amount of drugs was carried out using an Agilent 8543 UV-visible 
spectrophotometer (Agilent Technologies, CA, USA) at 221 nm. All the experiments 
were performed in triplicate and average values are reported.  
 
2.3 Results and Discussion 
 
2.3.1 Effect of FEM Operating Conditions on the Particle Size 
The effects of experimental conditions on particle size of ibuprofen (pre-mixed with 1.0 % 
of silica) were investigated. A series of experiments under different conditions were 
performed and listed in Table 2.1. The feeding pressure was kept constant at 30 psi. The 
effect of grinding pressure and feeding rate on particle size is depicted in Figure 2.2. At a 
constant feeding rate, an increase in grinding air pressure leads to a decrease in resulting 
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median particle size due to more energy input to the feed powders, leading to faster 
particle movement in the grinding chamber and more intense particle-particle and 
particle-wall collisions. This reduces the particle size.  The effect of feeding rate on 
milling behavior is also shown in Figure 2.2. It is evident that under the same grinding 
pressure, a higher feeding rate results in larger ground particles. This may be attributed to 
the shorter residence time of particle in the grinding chamber and lower kinetic energy 
available for grinding, resulting in some large particles leaving the milling chamber 
sooner [43, 50]. In addition, span [(d90 - d10)/d50] calculated from the particle size 
distribution is also shown in Table 2.2. It is observed that at fixed grinding pressure, an 
increase in feeding rate increases the span, implying wider particle size distributions. 
 
 
Figure 2.2 Effect of experimental conditions on particle size. 
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These results show that it is possible to control the particle size in the FEM by 
altering the experimental conditions. Varying the grinding pressure and feeding rate, as 
received ibuprofen (102.8 microns) was successfully micronized into particles smaller 
than 20 microns. Particle size of samples along with the brief sample description is listed 
in Table 2.2. Samples DC-IBU-5 and DC-IBU-10 have median particle size of 5.5 
microns and 10.9 microns, respectively. The shapes of particle size distribution for both 
powders are almost same with a relatively narrow size distribution as shown in Figure 2.3. 
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Figure 2.3 Particle size distribution of as received ibuprofen and 
micronized samples: DC-IBU-5 and DC-IBU-10. 
 
2.3.2 Morphology from SEM 
SEM images of as received and processed ibuprofen are shown in Figure 2.4. As depicted 
by Figure 2.4a-b, the rod shaped original ibuprofen particles have rough surfaces and 
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high aspect ratio (length over width, [63]) of approximately 5. This highly non-spherical 
shape is expected to affect the flow properties and bulk density [40]. When pure 
ibuprofen was micronized in the FEM, micronized particles are found to adhere to each 
other due to strong inter-particle force and form irregular shape agglomerates (as shown 
in Figure 2.4c-d). This greatly affects the flowability of ibuprofen. This phenomenon will 
be discussed further in section 2.6. In contrast, after FEM processing of ibuprofen with 
silica coating, ibuprofen was found to be micronized into fine and more spherical 
particles (as shown in Figure 2.4e-f). In addition, silica coating reduces the adhesion 
force among particles; as a result tendency to form agglomerates decreased greatly 
(Figure 2.4e). This is expected to improve the flowability of ibuprofen powder [40]. 
 
(a) 
 
Figure 2.4 SEM images of ibuprofen powders: (a-b) As-received-IBU, (c-d) UC-IBU-10 
and (e-f) DC-IBU-10, continued. 
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(b) 
 
(c) 
 
Figure 2.4 SEM images of ibuprofen powders: (a-b) As-received-IBU, (c-d) UC-IBU-10 
and (e-f) DC-IBU-10, continued. 
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(d) 
 
(e) 
 
Figure 2.4 SEM images of ibuprofen powders: (a-b) As-received-IBU, (c-d) UC-IBU-10 
and (e-f) DC-IBU-10, continued. 
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(f) 
 
Figure 2.4 SEM images of ibuprofen powders: (a-b) As-received-IBU, (c-d) UC-IBU-10 
and (e-f) DC-IBU-10. 
 
2.3.3 Effect of Amount of Silica 
The effect of amount of silica on the flowability of powder was studied. All DC-IBU-10 
samples were processed with different amount of silica under same experimental 
conditions (grinding pressure =10 psi, feeding pressure = 30 psi and feeding rate =5.7 
g/min). For sample UC-IBU-10, as mentioned before, different experimental conditions 
were applied to produce powders with comparable size. The median size of all the 
samples is about 10 microns. The angle of repose results after the FEM process with 
different weight percentage of silica coating are shown in Figure 2.5. It is observed that 
with increasing the silica content from 0 wt% to 1.0 wt%, the AOR decreases from 53
°
 to 
38
°
 which indicates that increasing the amount of nano-silica the flowability of the 
processed powder is improved. The results indicate that 1.0 wt% of silica is the optimum 
coating amount, because further increase of nano-silica (up to 5.0 wt%) does not affect 
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the AOR much (about 38°). Similar experimental procedures were followed with DC-
IBU-5 samples (grinding pressure = 30 psi, feeding pressure = 30 psi and feeding rate = 
10 g/min), and it was found that the optimum amount of silica for 5 microns powders is 
4.0 wt%, which makes sense because of the increase in specific surface area for finer 
powder. Thus, in the following section, all the flowability results of 5 and 10 microns 
powders are based on 4.0 wt% and 1.0 wt% silica coating, respectively. 
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Figure 2.5 Angle of repose of ibuprofen after FEM process with different weight 
percentage of silica (Median particle size for all the powders are 10 µm). 
 
2.3.4 Effect of FEM Process on Flowability and Bulk Density 
The angle of repose results for 5 microns and 10 microns ibuprofen samples are 
summarized in Table 2.3. In terms of powder flow, it is considered that the angle of 
repose (AOR) in the range of 30–35° indicates excellent flowability and angle of repose 
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less than 40° is considered to be acceptable [54]. Table 2.3 shows that the as-received-
IBU is cohesive and does not flow well and the corresponding angle of repose is 53.0°. 
For the 10 microns uncoated sample UC-IBU-10, the AOR is 53°, which is considered in 
“bad” flow range. While for the dry coated DC-IBU-10 sample, the AOR is reduced to 
less than 40°, 15° lower than the uncoated and also the as-received-IBU. This indicates 
that after dry coating the flowability is significantly improved and silica coating played 
an important role in improving the flowability. Similar flow improvement was observed 
in a previous dry coating study [32], where 15 µm cornstarch was dry coated in 
hybridizer using 1 wt% of 20 nm nano-silica. The angle of repose decreased from 52° to 
30°. For the uncoated sample UC-IBU-10, it has approximately the same angle of repose 
as the as-received-IBU. This may be due to the low sensitivity of the angle of repose for 
very cohesive powders; however it clearly indicates that the micronized powder has poor 
flowability. It is also likely due to the agglomeration among the pure micronized particles, 
which are much smaller than the as-received-IBU tending to form larger agglomerates as 
confirmed by actual photographs of these powder samples (Figure 2.6a). Comparison of 
actual images of DC-IBU-10 and UC-IBU-10 are shown in Figure 6. Large agglomerates 
are observed for sample UC-IBU-10, while no visual agglomeration is observed for 
sample DC-IBU-10. The angle of repose for corresponding co-ground sample (DC-IBU-
PVP-10) is 36°, which is slightly less than DC-IBU-10. The AOR results indicate that 
simultaneous micronization and dry coating in FEM is a successful way to produce 
micro-sized particles with improved flowability ascribed to the nano-sized silica coating 
on the surface. The ibuprofen samples, when milled to 5 microns (DC-IBU-5 and UC-
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IBU-5), had comparable angles of reposes to their 10 micron counterparts (DC-IBU-10 
and UC-IBU-10). These values are also listed in Table 2.3.  
 
(a) 
 
(b) 
 
Figure 2.6 Images of FEM processed samples: (a) UC-IBU-10 and (b) DC-IBU-10. 
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Table 2.3. FT4 Results Summary  
 
AoR (°) 
Bulk 
Density 
(g/ml) 
FFC 
Cohesion 
(kPa) 
Specific 
Energy 
(mJ/g) 
As-received-IBU 53.0 (0) 0.45 3.9 (0.17) 0.40 (0.03) 7.0 (0.32) 
As-received-PVP 36.3 (0.6) 0.45 8.1 (1.39) 0.18 (0.02) 3.4 (0.11) 
UC-IBU-10 53 .0 (2.2) 0.19 1.0 (0.08) 1.37 (0.15) 7.4 (0.10) 
DC-IBU-10 38 .0  (0.5) 0.33 6.1 (0.86) 0.24 (0.03) 2.5 (0.21) 
UC-IBU-PVP-10 54.8 (2.1) 0.24 1.1 (0.20) 1.38 (0.83) 8.0 (0.25) 
DC-IBU-PVP-10 36.0 (0.7) 0.48 5.9 (0.41) 0.23 (0.02) 4.2 (0.12) 
UC-IBU-5 55.1 (1.8) 0.20 1.1 (0.10) 1.36 (1.73) 11.1 (0.92) 
DC-IBU-5 38.0 (0.7) 0.23 4.7 (0.10) 0.28 (0.02) 3.0 (0.18) 
Standard deviations are shown in the parentheses. For bulk density, standard deviation is now shown 
because of the very low values. 
  
36 
 
 
 
In addition to the angle of repose test, flow properties of different ibuprofen 
samples were characterized with the FT4 powder rheometer and the results are shown in 
Table 2.3. The results from the shear test are very reproducible showing less variability in 
the predictions of the powder flowability. The as-received-IBU is cohesive with a flow 
function coefficient (FFC) of 3.9. FEM processed uncoated sample, UC- IBU-10 can be 
classified as very cohesive (FFC=1.0) and has very low bulk density of 0.19 g/ml. After 
FEM processing with silica (dry coated), DC-IBU-10, not only the FFC increased by 6 
times to 6.1 but also the density increased by 1.7 times to 0.33 g/ml.  These results 
confirmed that dry coated sample (DC-IBU-10) has much better flowability and can be 
identified as easy flowing powder. This also clearly indicates that the disadvantages of 
simple micronization, such as poor flow and low bulk density, can be eliminated by 
simultaneous micronization and surface modification. It is believed that the increased 
flowability of ibuprofen is due to the reduced inter-particle adhesion force between the 
surface modified ibuprofen particles [32, 36]. In fact the FFC for sample DC-IBU-10 
(~10 µm) is even higher than the as-received-IBU (~100 µm). Similar improvement in 
flowability and bulk density for 5 micron samples was observed and results are 
summarized in Table 2.3. 
The results for co-grinding with PVP are also shown in Table 2.3. Comparing the 
FFC and bulk density of samples (DC-IBU-PVP-10, UC-IBU-PVP-10 and DC-IBU-10), 
it is clear that the surface modification helps improve the flowability of the powders, and 
co-grinding with PVP helps to further increase the bulk density of the powder, without 
having any adverse effect on powder flow. SE values and cohesion also confirm that 
powder flow is improved for dry coated samples reflected by significantly lower SE 
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values below 5 and low cohesion (Table 2.3). All the results from FT4 rheometer also 
correlate well with the AOR results from Hosokawa powder tester. Thus surface 
modification and co-grinding are effective in improving flow while eliminating the 
disadvantages of simple micronization. 
As mentioned in the introduction, both the flowability and bulk density are 
important parameters for powder processing as they may be used together as useful 
indicators of rank ordering of powder flow properties and assessment of various modes of 
property enhancements.  The ability to discern flow improvement through these two 
parameters is illustrated in a simple but informative phase map of FFC against bulk 
density in Figure 2.7. From this figure, three arrows indicate the extent of the 
improvement in both flow and bulk density after surface modification and/or co-grinding. 
For both the sizes (5 µm and 10 µm samples), dry coating and co-grinding in the FEM 
changed the powder from very cohesive to easy flowing powder and the bulk density 
improvements are significant.  
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Figure 2.7 Phase map: FFC vs. bulk density. 
 
2.3.5 Effect of FEM Process on Compressibility 
Compressibility is a characteristic measurement of powders indicating the ease of storage, 
handling and transport [54]. Lower compressibility indicates there is efficient packing 
among the particles and a minimal amount of excess air in the bulk, which is a desirable 
property for pharmaceutical powders intended for solid dosage forms. This typically 
occurs when the inter-particle cohesive forces are low in comparison to particles own 
inertial forces. Compressibility results for all the samples are presented in Figure 2.8. As 
seen, compressibility of all processed samples with silica coating and co-grinding (DC-
IBU-5, DC-IBU-10 and DC-IBU-PVP-10) is lower than as-received-IBU. In contrast, 
compressibility for pure micronized powders (UC-IBU-5, UC-IBU-10 and UC-IBU-
PVP-10) is higher than as-received-IBU. It can be concluded that over the range of 
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normal stress (1-15 kPa), dry coated micronized ibuprofen shows an improved 
compressibility property compared to both the pure micronized (without silica coating) 
and as received powders. Similar observation is also reported for mechanically dry coated 
samples [56]. 
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Figure 2.8 FT4 compressibility results. 
 
2.3.6 Effect of FEM Process on Dispersibility 
Generally, dispersibility of particles is significantly impacted by particle size and size 
distribution given that other particle or material properties are similar. As described by 
Kaye et al. [64], the gradient in d90 over the dispersion pressure range can be used as an 
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indication of the dispersibility for the powders. A smaller gradient indicates better 
dispersibility. Pressure titration curves of samples UC-IBU-10 and DC-IBU-10 along 
with co-ground sample DC-IBU-PVP-10 are shown in Figure 2.9. It can be observed that 
for pure micronized powders without surface modification, there is a sharp drop in the d90 
and d50 with increasing the dispersion pressure. This is believed to be an indication of 
deagglomeration, which is confirmed by SEM imaging (Figure 2.4c, d). It can also be 
observed that the dry coated micronized powders (DC-IBU-10) and the co-ground/coated 
powders (DC-IBU-PVP-10) have fairly flat pressure titration curves. It is evident from 
these plots that there is a clear difference in dispersibility between the micronized 
ibuprofen powders with and without silica coating. The smaller gradients of the dry 
coated ibuprofen curves indicate that even at low pressures, the dry coated powders are 
relatively well dispersed, which is also corroborated from the SEM images (Figure 2.4e 
and 2.4f).    
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(b)  
 
Figure 2.9 Pressure titration curves: d 90 (a) and d 50 (b) for sample 
UC-IBU-10, DC-IBU-10 and DC-IBU-PVP-10. 
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2.3.7 Effect of FEM Process on Electrostatic Charge Tendency 
The tendency of fine powders to electrostatically charge, especially during dry 
micronization is a major problem in pharmaceutical manufacturing [65]. Figure 2.10 
shows preliminary experiments to measure the electrostatic charge of the pure and silica 
coated ibuprofen after FEM processing, which were performed at a temperature of 
17.8 °C and relative humidity of 15%. It can be seen that the electrostatic charge for the 
pure micronized sample is very high, which may affect downstream processing. It is also 
likely that certain idle time may be required to allow dissipation of charge before powder 
unloading, which adversely impacts the processing time and efficiency. It was observed 
that discharging and transferring these powders between processing equipment was 
indeed difficult and a significant amount of powders stick to the equipment. In contrast, 
for the micronized dry coated sample the electrostatic charge is significantly reduced as 
compared to the uncoated micronized powders. This indicates that proposed coating and 
micronization process can produce fine powders with reduced electrostatic charge. In a 
future study, a more comprehensive investigation will be carried out to determine the 
influence of processing parameters and material properties (API particles as well as 
coating material) on the electrostatic charging tendency. 
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Figure 2.10 Electrostatic charge test results for sample UC-IBU-10 and DC-IBU-10. 
 
2.3.8 Effect of FEM Process on Crystallinity 
The crystallinity of a pharmaceutical substance has an effect on its dissolution and 
bioavailability, and on its physical and chemical stability. Most of the pharmaceutical 
products are formulated to contain drug in the stable crystalline form due to the long-term 
stability concerns with respect to amorphous and unstable crystal forms. Therefore, it is 
necessary to evaluate the effect of FEM process on crystallinity. XRD studies show that 
unprocessed ibuprofen (as-received-IBU) and processed ibuprofen (DC-IBU-10) powders 
have nearly same patterns and peak positions (2θ values, Figure 2.11).  This suggests that 
the milling process for ibuprofen does not induce a polymorphic transition or 
amorphization. However, the slight difference in the relative intensities of their peaks 
may be due to differences in the particle sizes [66].  
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A DSC study was performed; the result indicates that the as-received-IBU has a 
single endothermic peak at 76.4 °C, due to the melting of the drug. This result is similar 
to the one reported by Charoenchaitrakool, M. et al. [67]. DSC curves of processed 
ibuprofen with or without silica show similar single endothermic peak at about 76°C. 
Moreover, the degree of crystallinity for the dry coated sample is 98.6 % calculated by 
equation 2.1.  
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Figure 2.11 XRD spectrum results for sample: as-received-IBU, DC-IBU-10 and Silica 
M5P. 
 
In addition, Raman spectra were performed (Figure 2.12). Similar to XRD results, 
Raman studies show that unprocessed ibuprofen (as-received-IBU) and processed 
ibuprofen (DC-IBU-10 and DC-IBU-PVP-10) powders have nearly the same patterns and 
peak positions. Raman results along with DSC and XRD results confirm that after FEM 
Silica M5P 
DC-IBU-10 
As-received-IBU 
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process, ibuprofen retains its crystal form, indicating there is minimal detectable physical 
transformation with FEM processed ibuprofen.  
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Figure 2.12 Raman spectrum for sample: as-received-IBU, DC-IBU-10 and DC-IBU-
PVP-10. 
 
It should to be pointed out that although the XRD, DSC and Raman tests were 
performed as soon as the samples were prepared, indeed recrystallization of the 
disordered fraction during the course of the measurement was not considered in this 
chapter. The limit of quantification of amorphous content for XRD method is about 5%, 
DSC is about 1%. 
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2.3.9 Effect of FEM Process on Dissolution 
The dissolution profiles of as-received-IBU and the processed ibuprofen are shown in 
Figure 2.13. From the figure, it can be seen that the increase in the dissolution rate occurs 
in the following order: DC-IBU-PVP-10 > DC-IBU-10 > As-received-IBU > UC-IBU-10. 
The enhanced dissolution rate for sample DC-IBU-10 as compared to the original, as well 
as FEM processed without silica, is attributed to the highly dispersible non-agglomerated 
micronized powders resulting from the simultaneous surface modification and 
micronization. It is also believed that the hydrophilic nano-silica on the surface enhances 
the surface wettability and will further improve the dissolution rate. The co-ground 
powder DC-IBU-PVP-10 exhibited the fastest dissolution rate, which is likely due to the 
enhanced dispersibility imparted by the nano-silica as well as the hydrophilic and highly 
water-soluble nature of PVP. The slower rate of dissolution of pure micronized ibuprofen 
without surface modification (UC-IBU-10) than as-received-IBU is most likely due to 
heavy agglomeration of micronized powder which tend to trap air inside and delays the 
dissolution in aqueous medium consistent with the observations from literatures. Perrut et 
al. [15] discussed similar dissolution trends for both bulk and micronized powders, in 
which the micronized powders (4 µm) had a slower dissolution rate compared to the bulk 
powders (29 µm). In [16], dissolution rate was compared for micronized powders before 
and after dispersion. It was shown that agglomerated powders had slower dissolution rate 
compared to those after dispersion. In addition, the dissolution profile characteristics also 
corroborate the particle sizes from Rodos/Helos system at low dispersion pressure (0.2 
bar): the d50 for sample UC-IBU-10 is 359.4 µm which shows significant agglomeration, 
134.3 µm for as-received-IBU and 11.7 µm for DC-IBU-10. In addition, the dissolution 
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profile time constants t [67], (which is defined as the time required to dissolve 80% of the 
original material) are also shown in Figure 2.13. It can be seen that the constants for as-
received-IBU and UC-IBU-10 are almost the same, indicating that the agglomeration of 
pure micronized powder leads to lack of improvement in the dissolution rate. On the 
other hand, the time constant for sample DC-IBU-10, t2, is much smaller than that of both 
as-received-IBU, t3, and the pure micronized (uncoated) sample, t4, indicating that 
micronization with surface modification results in faster dissolution rate which is what 
one would expect from micronization. When simultaneous micronization and surface 
modification also included co-grinding with PVP, the time constant, t1, further decreased 
indicating further improvement in dissolution rate.  
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Figure 2.13 Powder dissolution profile. 
 
Corresponding BET results are shown in Table 2.4 where the specific surface area 
for sample DC-IBU-10 is about 25 times higher than the as received ibuprofen. Assuming 
1 
2 
3 
4 
48 
 
 
 
powders are spherical, if particle size decreases 10 times, then specific surface area 
should increase 10 times accordingly (from 0.15 m
2
/g to 1.5 m
2
/g). The BET results show 
that the micronized and dry coated DC-IBU-10 powder has much higher surface area 
than 1.5 m
2
/g. Since the specific surface area of nano-silica M5P is about 200 m
2
/g, 1 wt% 
would correspond to about 2 m
2
/g of additional increase in specific surface area. Thus the 
observed value of 3.8 m
2
/g from the BET results for DC-IBU-10 seems reasonable. This 
increase in the specific surface area is partially explained by the presence of the nano 
silica but much of it comes from micronization, indicating enhanced dispersibility and 
diminished agglomeration.  It also suggests that nano-sized silica is coated/distributed on 
the surface and is not just present as agglomerates as would be in case of a physical 
mixture. In contrast, specific area for sample UC-IBU-10 is only 2.3 times greater than 
the as received sample, which is lower than expected based on the size reduction. This 
corroborates the evidence from the pressure titration and dissolution experiments, which 
suggested that there is significant agglomeration in the pure milled ibuprofen. Perhaps it 
is the main reason why this micronized sample has no improvement in the dissolution 
rate as compared to the as received sample. These results indicate that micronization 
without surface modification does not usually improve the dissolution rate as expected; 
while higher specific surface area, better dispersibility, and better wettability may be the 
reasons for the improved dissolution rate for both dry coated and co-ground samples. 
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Table 2.4. BET Results 
Standard deviations are shown in the parentheses. 
 
2.4 Summary and Conclusions 
In this chapter, simultaneous micronization and surface modification of Active 
Pharmaceutical Ingredient (API) was considered. The main objective of the work was to 
perform micronization in order to achieve dissolution rate improvement while eliminating 
typical disadvantages of micronization such as, agglomeration, poor flowability, loss of 
expected large surface area, low bulk density, and insignificant or no dissolution 
improvement. The process utilized in this work was a continuous fluid energy mill (FEM) 
where larger API particles of ibuprofen selected as a model drug, pre-blended with nano-
silica were micronized to achieve fine surface modified API particles via nano-silica dry-
coating. The FEM process optimization confirmed that the feeding rate and the grinding 
pressure are critical parameters for achieving the desired particle size with relatively 
narrow size distribution. Through this process, ibuprofen was micronized from 102 µm 
(as received) down to 10 µm and 5 µm, and was simultaneously dry-coated with 
hydrophilic nano-silica. The results for various critical properties of the surface modified 
micronized (dry-coated) powders were evaluated and compared with as received 
ibuprofen powder and micronized ibuprofen without surface modification.  
 
As-received-IBU DC-IBU-10 UC-IBU-10 
Specific surface area 
(m
2
/g) 
0.1477 (0.003) 3.7588 (0.11) 0.3347 (0.05) 
Ratio of specific area  
for processed and as 
received IBU 
- 25.4 2.3 
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The results showed significant improvement in flow properties and dissolution 
rate when micronization was performed in conjunction with surface modification. 
Preliminary experiments also indicated that micronized powders that were surface 
modified collected significantly less charge during processing as compared to those that 
were not surface modified. In addition to size reduction along with dry coating, co-
grinding with small amount of water-soluble polymer during the micronization process 
was carried out and found to further improve dissolution rate along with increased bulk 
density. The surface modified, micronized powders showed improved dispersion, 
significantly higher bulk densities, and higher flowability, i.e., the flow function 
coefficient (FFC ≥ 6, from shear tests). High bulk densities (> 0.4 g/cc) and FFC (≥ 6) 
suggest that these fine APIs can be used in formulations that may be amenable for direct 
compression with high drug loading (assuming the API has good compressibility 
properties) and would achieve expected increase in dissolution rates due to micronization. 
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CHAPTER 3 
DRY COATING OF MICRONIZED API POWDERS FOR IMPROVED 
DISSOLUTION OF DIRECTLY COMPACTED TABLETS WITH HIGH DRUG 
LOADING 
3.1 Introduction 
Fine particles (< 25 µm) have attracted significant interest both from academia and 
industry. In the pharmaceutical industry fine drug particles have the potential benefit of 
improved dissolution rate due to their high surface area [3-6] as indicated by the Noyes-
Whitney equation [7]. Micronization often results in high relative cohesion that is largely 
due to the strong van der Waal force of attraction among dry particles. The highly 
cohesive nature of the fine powders can lead to downstream processing issues related to 
their poor flowability and low bulk density [34, 51].  
The importance of flowability of powders for successful manufacture in the food 
and pharmaceutical industry is well-documented in the literature, especially for fine 
powders where the flow properties are particularly poor [18, 19]. Traditional methods to 
improve the powder flow involve aeration, vibration and/or addition of flow agents [68-
70]. However, these approaches typically provide inconsistent or unreliable results and 
may lead to segregation and non-uniform distribution of the flow additives in the bulk 
[68-71]. Over the years, many methods have been developed to improve the flowability 
of the fine powders [40, 41]. In the pharmaceutical industry, wet and dry granulation are 
commonly used to increase the granule size and ease the problem of powder handling. 
This requires additional complex and expensive processing steps in contrast to a method 
like direct compaction, which is simple and cost effective. However, when fine, 
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micronized active pharmaceutical ingredients (APIs) are used with an objective of 
improving dissolution properties, it is likely that other conventional approaches, 
including granulation may be counter-productive because they may not preserve the 
increased API surface area [15, 16]. 
In order to make direct compaction feasible, APIs and their blends must flow well 
and have sufficiently high bulk densities. Unfortunately, this cannot be achieved through 
current approaches for fine API based formulations having greater than 10 or 20 % active 
loadings without employing granulation. Thus it would be desirable to develop 
approaches that allow for reliable flow improvements and increased bulk densities that 
can lead to direct compaction formulations at high drug loadings with desirable tablet 
properties, without requiring dry or wet granulation.    
It has been shown by authors’ group that surface modification by dry particle 
coating is a simple and effective route for improving the flowability of fine powders [31, 
32]. In the surface modification by dry coating process, nano-particles are used as guest 
particles which coat the surface of the host particles and create a nano-scale roughness, 
hence reducing the cohesive force among dry coated host particles [32, 34, 42]. Previous 
work also shows that dry coating makes a substantial improvement in the flow properties 
of the pharmaceutical powders [72-74], where the flow function coefficient (a reliable 
measure of powder flow) and bulk density of these powders fall in the range for direct 
compaction [71, 72], based on the previously developed bulk density – FFC phase map 
[74, 75]. Based on the particle size, there are two different approaches for dry coating 
[75]. The first approach is usually for particles > 25 µm employing a Magnetically 
Assisted Impaction Coater (MAIC) or a continuously operating cone-mill, or hereafter 
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called comil [76], where attrition of particle size is kept to a minimum. The second 
approach, where simultaneous micronization and surface modification is employed using 
a fluid energy mill (FEM), is suitable for finer particles (< 25 µm) including those used in 
the inhalation application (~ 2 to 5 µm), where materials such as amino acid instead of 
nano-silica are used for dry coating [75]. Different active pharmaceutical ingredients 
(APIs) and excipients have been tested using both approaches [72-74] with success. In a 
preliminary investigation using the comil [74, 76], it was reported that dry coating of API 
has no negative effect on downstream products and results in improved performance 
(blend flow property, tablet hardness) when surface modified API is used. In this work, 
the second approach, which is simultaneous micronization and dry coating in a FEM, is 
investigated for fine API particles (< 25 µm), which is somewhat difficult to achieve in a 
comil, and the effect on blend properties, direct compaction and tablet dissolution are 
studied. The FEM is a continuous method that is scalable, and is frequently used in the 
pharmaceutical industries [12, 66] and has gained significant research interest [43, 72, 77, 
78]. Thus it is ideally suitable for the main objective of this work, namely, to investigate 
the effect of dry coating of fine micronized API powders on dissolution of directly 
compressed tablets with high drug loading.  
Ibuprofen which is a type of Biopharmaceutics Classification System (BCS) class 
II drug (molecular weight 206.28 g/mol, aqueous solubility < 0.1 mg/ml [47, 48]) was 
selected as a model poorly water-soluble drug. In addition, ibuprofen is also known as 
having poor flow and compaction behavior when it is fine. Although direct compaction is 
desired, in most cases granulation is performed before tabletting [79]. In order to process 
ibuprofen via direct compaction, physico-mechanical properties of ibuprofen was 
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changed through simultaneous micronization and surface modification using the nano-
silica in the FEM. The dry coated API powders were then formulated into blends with 
different drug loadings (30%, 60% and 70%). Blends containing fine API particles (~ 20 
µm) have been studied for their flow properties. Blends containing 50 µm API particles 
dry coated using the comil are also studied for benchmarking. In addition to the dry 
coated 20 µm and 50 µm blends, the corresponding uncoated API powder blends are 
studied for comparison. 
 
3.2 Experimental 
3.2.1 Materials and Methods 
Ibuprofen 50 was purchased from BASF (NY, USA), with volume based d10, d50 and d90 
as the following: 16 µm, 58 µm and 148 µm. The excipients included pharmaceutical 
grade amorphous hydrophilic silica (M5P, Cabot Corporation, MA), microcrystalline 
cellulose (Avicel PH-102, FMC BioPolymer, Newark, DE), spry dried hydrous lactose 
(pharmatose DCL-11, DMV, Delhi, NY), magnesium stearate (Mallinckrodt Inc, St Louis, 
Missouri). Crospovidone (Kollidon-CL) was received as a gift from BASF (Ledgewood, 
NJ). Volume based particle size distribution of the powders was measured by the 
Rodos/Helos system, which is a laser diffraction particle analyzer (Rodos/M and 
Helos/BR, Sympatec, NJ). Size statistics in terms of d10, d50 and d90 are reported, which 
are the values of the particle diameter at 10%, 50% and 90% respectively in the 
cumulative volumetric particle size distribution. In the Rodos/Helos system, the Rodos 
device works by venturi principle to disperse the powder, and the HELOS unit uses laser 
diffraction principles of Fraunhofer Enhanced Evaluation (FREE) and Mie Extended 
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Evaluation (MIEE) theories of light scattering to determine the particle size. Size 
statistics of d10, d50 (median size) and d90 at dispersion pressure of 0.5 bar are reported 
(Table 3.1). 
 
Table 3.1 Particle Size Distribution of Ibuprofen and Excipients 
  d 10 (µm) d 50 (µm) d 90 (µm) Span* 
Ibuprofen 50  16.1 57.9 146.7 2.3 
Avicel PH102 32.0 122.4 244.4 1.7 
Pharmatose DCL-11 42.3 107.5 194.4 1.4 
Crospovidone Kollidon-CL 16.2 75.2 214.2 2.6 
Magnesium stearate - 4.2 -  
Silica M5P - 0.016 -  
*Span= (d90- d10)/ d50  
 
Ibuprofen samples were dry coated using two different approaches. Ibuprofen was 
micronized down to 20 µm (median size) and was dry coated in the FEM (qualification 
model, Sturtevant Inc., Hanover, MA) and 50 µm (median size) ibuprofen was dry coated 
in the comil (U3 quadro comil, Quadro, Millburn, NJ). Dry coated ibuprofen powders 
were then used for blend preparation. Corresponding uncoated ibuprofen powders (20 µm 
and 50 µm) were used to prepare uncoated API blends. Flow properties of all the blends 
were characterized via angle of repose, bulk density, flow function coefficient and 
compressibility. To study the tablets and its dissolution, blends of 20 µm ibuprofen (both 
coated and uncoated) were considered.  
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3.2.2 Scanning Electron Microscope (SEM) 
Particle morphology of particles was examined using a Field Emission Scanning Electron 
Microscope (FESEM) (LEO 1530 170, Carl Zeiss SMT Inc.)  All the powder samples 
were pre-coated with carbon by sputter coater to enhance conductivity under FESEM. 
3.2.3 Preparation of Dry Coated and Uncoated Samples 
3.2.3.1 Preparation of Micronized Dry Coated and Uncoated Samples in Fluid Energy 
Mill (FEM). A detailed description of preparation of dry coated and uncoated samples 
using FEM was discussed in Chapter 2 
Selection of the amount of silica is critical for the flow improvement and may 
affect subsequent tablet properties. The amount of silica used was determined to ensure 
cohesion reduction. Theoretical estimates for silica amounts for 100 % surface area 
coverage (to ensure best level of cohesion reduction) can be based on a simple equation, 
which requires average quantities such as guest and host particle sizes and their densities, 
presented in [32]. While in general 100 % coverage is recommended, optimal surface 
coverage may also be estimated based on the advanced models presented in [29]. 
However, in the current work, optimum silica amount was determined using the 
experimental method described in [72] and was kept at 1 wt% based on the pervious 
study [72]. More specifically, the experimental procedure involved examining flow 
properties (using either angle of repose or flow function coefficient as an indicator) of 20 
µm dry coated ibuprofen with different weight percentage of silica. Based on that 
procedure, the optimum amount of silica for 20 µm ibuprofen was found to be 1 wt%. 
Experimental conditions for making dry coated 20 µm ibuprofen were: feeding pressure 
of 20 psi, grinding pressure of 15 psi and solid feeding rate of 5.9 g/min. Similar feeding 
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and grinding pressure were used and solid feeding rate was adjusted to various values to 
make uncoated 20 µm ibuprofen. We note that the as received ibuprofen (without pre-
mixed with silica) is cohesive and it is hard to control the feeding rate, and hence it 
cannot be matched exactly with that of the pre-mixed ibuprofen used in dry coated case. 
As a result, multiple runs were required to collect 20 µm uncoated ibuprofen.  
3.2.3.2 Preparation of Dry Coated Samples Without Size Reduction in Comil. Dry 
coating of samples without size reduction was performed in a conical screen mill-comil 
(Quadro, Millburn, NJ). Pre-mixing of API powders and nano-silica was performed in a 
0.5 pint V-blender for 5 min (125 revolutions). Pre-mixed powders were then fed into the 
comil by using a volumetric feeder (Schenck Accurate) and dry coated powders were 
collected from the bottom of the comil. Based on a preliminary comil optimization study 
[74], the following experimental conditions were chosen: solid feeding rate of 10.0 g/min, 
round shape impeller, impeller RPM of 1300 rpm, and screen opening size of 457 
microns. For the sake of consistency with the study in [74], as well as the FEM based 
coating, the amount of silica was kept at 1 wt%. The particle size distribution of the four 
different types of ibuprofen studied is listed in Table 3.2. 
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Table 3.2 Particle Size Distribution of Uncoated and Dry Coated 20 µm and 50 µm 
Ibuprofen   
  d 10 (µm) d 50 (µm) d 90 (µm) Span 
Uncoated 20 µm ibuprofen 6.0 20.7 48.2 2.0 
Dry coated 20 µm ibuprofen 2.7 19.1 48.2 2.4 
Uncoated 50 µm ibuprofen  16.1 57.9 146.7 2.3 
Dry coated 50 µm ibuprofen 18.0 61.3 150.1 2.2 
 
3.2.4 Preparation of Blends 
Micronized and dry coated ibuprofen powders (~20 µm) from the FEM along with the 
other excipients listed in Table 3.3 (except magnesium stearate) were blended in a 0.5 
pint V-blender at 25 rpm for 12 min. Magnesium stearate was screened and added to the 
blender for additional 30 revolutions to get blend of 20 µm dry coated ibuprofen. For 20 
µm uncoated blend, similar procedure was followed by using uncoated micronized 
ibuprofen (~20 µm). Three drug loadings were prepared: 30%, 60% and 70%. Placebo 
blend (API free blend) was prepared following the same procedure using the formulation 
listed in Table 3.3. 
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Table 3.3 Formulation for Dry Coated and Uncoated Blends at Three Different API 
Loadings 
Dry Coated Blend Placebo 
Ingredients 
30% loading 
Amount (%) 
60% loading 
Amount (%) 
70% loading 
Amount (%) 
Amount 
(%) 
Dry coated 
API 
30.3 60.6 70.7 0 
Pharmatose 
DCL-11 
31.85 16.7 11.65 47 
Avicel PH-
102 
31.85 16.7 11.65 47 
Crospovidone 5 5 5 5 
Magnesium 
stearate 
1 1 1 1 
 
Uncoated Blend 
Ingredients 30% loading 
Amount (%) 
60% loading 
Amount (%) 
70% loading 
Amount (%) 
Uncoated API 30 60 70 
Silica M5-P 0.3 0.6 0.7 
Pharmatose DCL-11 31.85 16.7 11.65 
Avicel PH-102 31.85 16.7 11.65 
Crospovidone 5 5 5 
Magnesium stearate 1 1 1 
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For blends of 50 µm ibuprofen, similar procedure was followed, where 50 µm 
ibuprofen was dry coated without size reduction in the comil (the first approach of dry 
coating mentioned earlier) instead. The blend formulation is shown in Table 3.3. The 
blends of uncoated ibuprofen were prepared with as received ibuprofen using the same 
formulation.  
In total, four types of blends were investigated in the study: (i) blend containing 
50 µm dry coated ibuprofen, (ii) blend containing 20 µm dry coated ibuprofen, (iii) blend 
containing 50 µm uncoated ibuprofen, (iv) blend containing 20 µm uncoated ibuprofen.  
 
3.2.5 Powder and Blend Flow Behavior 
a. Angle of Repose Test 
A detailed description of angle of repose test can be found in Chapter 2, section 2.2.3. 
b. Powder/Blend Characterization Using FT4 Powder Rheometer 
A detailed description of FT4 powder rheometer can be found in Chapter 2, section 2.2.3. 
3.2.6 True Density of Blends 
The true density (ρ true) of each blend was determined by a helium pycnometer (NOVA 
3200, Quantachrome instruments, Boynton beach, FL). The experimental sample was 
accurately weighed and loaded into the sample cell. The sample volume was computed 
by measurements of the pressure observed by filling the sample chamber with nitrogen. 
The measurements were repeated for 7 such cycles. Each sample was tested twice and 
average values are reported. 
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3.2.7 Tabletting Performance 
Tablets, weighing about 500 mg, were prepared on an Instron 5567 (Instron, Norwood, 
MA) at different compression pressure ranging from 40 MPa to 140 MPa, using a flat, 
round punch and a die with a diameter of 12.7 mm. The punch speed was programmed at 
1.5 mm/s. Each tablet was weighed accurately and its dimensions (diameter and thickness) 
were measured with a digital slide caliper (Starett, L.S. Starett Co., Athol, MA). At each 
compression pressure, three tablets were prepared.  
The apparent density (ρ app) of the tablet was calculated from the ratio of the tablet 
mass to the volume of the tablet.  The porosity (ε) of the tablet was calculated using 
equation 3.1.  
   
 (1 / )app true      (3.1) 
 
Tablet breaking force was measured using the Instron 5567 at a test speed of 0.5 
mm/s [80]. Tensile strength, σ, was calculated using equation 3.2, where F is the breaking 
force, D is the tablet diameter, and t is the thickness of tablet. 
  
 
2F
Dt


  (3.2) 
 
Compactibility is the ability of a powdered material to be transformed into tablets 
with strength during densification [81, 82]. Compactibility is important because it reflects 
the two most important parameters when pressure is applied on powders: tablet strength 
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and tablet porosity. Ryshkewitch equation [83] was used to fit the data (equation 3.3), 
where σ is tensile strength, σ 0 is tensile strength at zero porosity, b is a constant and ɛ is 
porosity. 
 
 0
be     (3.3) 
 
3.2.8 Tablet Dissolution 
Tablet dissolution studies were performed according to the USP II paddle method using a 
Distek 2100C dissolution apparatus (Distek Inc., NJ, USA) with a temperature control 
system (TCS 0200). The dissolution medium (900 ml) was phosphate buffer solution 
(pH= 7.2) with 0.4 g/L sodium dodecyl sulfate (SDS). The paddle rotating speed was 50 
rpm, and the temperature was maintained at 37 °C ± 0.2 °C. Tablets (~500 mg) were 
added to the dissolution apparatus for dissolution test. Liquid medium was collected at 
pre-determined time intervals, and filtered through a 0.45 µm filter for further 
quantitative test. Quantitative test of dissolved amount of drugs was carried out using a 
Thermo Evolution UV spectrophotometer (Thermo Scientific Inc., Rochester, NY) at 213 
nm. All the experiments were performed in triplicate and average values are reported.  
3.3 Results and Discussion 
In this section, flow characterization results of different blends are first presented for both 
20 µm (processed using the FEM) and 50 µm (processed using the comil) blends. The 
tablet compaction and dissolution results are presented for 20 µm blends with 30% and 
60% drug loading. 
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Representative SEM images of the uncoated and dry coated ibuprofen powders 
with two different sizes are shown in Figure 3.1. The 50 µm ibuprofen has a rod shape 
and silica coating is observed on the surface of the dry coated samples (Figure 3.1 c-d). 
For 20 µm samples, the uncoated micronized powders (Figure 3.1 e-f) show a tendency 
to agglomerate and in many cases the formation of solid bridges can be observed. In 
contrast, the dry coated powders (Figure 3.1 g-f) are not agglomerated due to the nano-
silica surface coating. The presence of the guest particles appears to prevent interactions 
between the host particles at this level of sparse coating, depicted in Figures 3.1 g-f, 
resulting in less agglomeration. The presence of nano-sized guest particles can influence 
both the surface roughness (modifies the contact radius and area between particles) and 
the surface energy (modifies the strength of interaction), which will reduce the cohesive 
force [34, 84] among the coated particles and ultimately improve the bulk powder 
behavior [29, 32, 34, 36-38].  These SEM images indicate the presence of nano-silica on 
the drug powder surfaces, indicating that both approaches result in dry coated powders as 
expected based on previous studies (Yang et al., 2005; Chen et al., 2008; Chen et al., 
2009a; Chen et al., 2010).  
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 (a)                                                                             
 
(b) 
 
Figure 3.1 SEM images of ibuprofen samples: (a-b) as received ibuprofen 50, (c-d) comil 
dry coated ibuprofen 50, (e-f) pure micronized ibuprofen 20 µm and (g-h) micronized 
and dry coated ibuprofen 20 µm, continued. 
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 (c)                                                                            
 
 
(d) 
 
Figure 3.1 SEM images of ibuprofen samples: (a-b) as received ibuprofen 50, (c-d) comil 
dry coated ibuprofen 50, (e-f) pure micronized ibuprofen 20 µm and (g-h) micronized 
and dry coated ibuprofen 20 µm, continued. 
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   (e)                                                                          
 
(f) 
 
Figure 3.1 SEM images of ibuprofen samples: (a-b) as received ibuprofen 50, (c-d) comil 
dry coated ibuprofen 50, (e-f) pure micronized ibuprofen 20 µm and (g-h) micronized 
and dry coated ibuprofen 20 µm, continued. 
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 (g)                                                                              
 
 
(h) 
 
Figure 3.1 SEM images of ibuprofen samples: (a-b) as received ibuprofen 50, (c-d) comil 
dry coated ibuprofen 50, (e-f) pure micronized ibuprofen 20 µm and (g-h) micronized 
and dry coated ibuprofen 20 µm, continued. 
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3.3.1 Blends Flow Property 
Figure 3.2 (a) presents angle of repose results for the 20 µm blends. It can be observed 
that uncoated (pure micronized) blends at all three drug loadings have AOR values higher 
than 40°, which is considered passable but as drug loading becomes higher, the value 
reaches 45°, which is considered poor flowing powder. On the other hand, the 
corresponding three FEM processed (dry coated in the FEM) blends have AOR less than 
40°, which indicates that they have fair flow and the AOR is nearly independent of the 
drug loading. Thus, as the drug loading increases, the AOR difference between the 
uncoated blend and the dry coated blend is more pronounced. Figure 3.2 (b) demonstrates 
the angle of repose results for blends consisting of 50 µm ibuprofen. In this case, the dry 
coated powders do not result in any significant decrease in the AOR, which is about 40°, 
which indicates that all the blends have acceptable flow properties. While not clear from 
AOR values, it was observed during the measurements that for the uncoated blends, 
agglomeration of API particles was pronounced. It is likely that this may lead to tablet or 
API weight variation during the manufacturing. Nonetheless, from the AOR results for 
non-micronized powder blends, one may surmise that dry coating is not highly 
advantageous. 
  
69 
 
 
 
(a)   
API loading
0% 30% 60% 70%
A
n
g
le
 o
f 
R
e
p
o
s
e
 (
d
e
g
re
e
)
30
35
40
45
50
Placebo
UC-20
DC-20 
 
(b) 
API loading
0% 30% 60% 70%
A
n
g
le
 o
f 
R
e
p
o
s
e
 (
d
e
g
re
e
)
30
35
40
45
50
Placebo
UC-50
DC-50
 
Figure 3.2 Angle of repose results for (a) 20 µm blends and (b) 50 µm blends. 
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 Figures 3.3(a) and 3.3(b) present the conditioned bulk density and FFC 
respectively for 20 µm blends (both uncoated and dry coated in the FEM) with 30%, 60% 
and 70% drug loading. In general, for fine API powders, increase in drug loading 
decreases the bulk density of the blends. The blend without any API (placebo or API free 
blend) has conditioned bulk density of about 0.47 g/ml, and as expected, the increase in 
uncoated drug loading from 30% to 60% shows gradual decrease in the conditioned bulk 
density (~0.45 g/ml). However, there is a sharp decrease in bulk density when drug 
loading increases to 70% (~ 0.37 g/ml), indicating that for uncoated powders, this drug 
loading is too high for direct compaction. In contrast, blends with dry coated ibuprofen 
(DC-20) yield higher bulk density (0.52 g/ml) even as compared to the placebo blend and 
this value remains nearly constant for all three drug loadings, including at the highest 
loading of 70 %. This clearly indicates superior performance of dry coated micronized 
powders in their packing efficiency (20 µm dry coated API: 0.45 g/ml; 20 µm uncoated 
API: 0.33 g/ml). There is substantial difference between the packing densities of blends 
containing uncoated and dry coated ibuprofen at 70% drug loading. Similar to the 
conditioned bulk density, the FFC for uncoated blends decreases with increasing the drug 
loading from about 4.8 for 30% loading to around 2.7 for 70% loading (Figure 3(b)), and 
all these values are considerably smaller than the placebo blend, showing clear impact of 
poor flowability of API powders subjected to micronization without surface modification. 
In contrast, blends with dry coated API powders have higher FFC (> 8) for all three drug 
loadings and the FFC value is comparable or even better than the API free blend. 
According to the FFC classification by Schulze [59], FFC of 10 is for free-flowing 
powders, hence, FFC ≅ 8 may be considered as the level at which the powders may be in 
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easy to free flowing regime. Thus, when comparing the uncoated blend with the dry 
coated blend with the same drug loading, dry coating improves the blends flowability to 
easy (FFC ≅ 8) or free flowing (FFC > 10) region. It is noted that the FFC values higher 
than 10 are considered to be practically the same [59] and also the shear test results from 
the FT4 tend to give high variation for free flowing materials, hence the FFC values are 
set to 10 in these plots for the sake of fair comparison instead of showing the actual FFC 
values. Since the variation for higher FFC (> 10) values is irrelevant, error bars are not 
shown for those cases.  
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Figure 3.3 Conditioned bulk density (a) and FFC value (b) for 20 µm blends. 
 
 Based on the bulk density and FFC results for dry coated API blends, one can 
conclude that micronization along with dry coating results in superior blends. As per [59, 
85], better packing and better flow properties go hand-in-hand, and hence these are well 
flowing powders. In industrial practice, a blend with high bulk density of at least 0.45 
g/ml and high FFC of at least 4, but preferably > 8 is required for continuous direct 
compaction [20]. The results for micronized, dry coated ibuprofen blends indicate that 
direct compaction is feasible for drug loadings as high as 70 %. Therefore, the FEM 
process as developed here could alleviate the need for dry or wet granulation and allow 
for employing simplified, low cost direct compaction for high drug loading formulations. 
Actual FFC >10 
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 Figure 3.4(a) and 4(b) illustrate the conditioned bulk density and the FFC results 
for blends containing 50 µm ibuprofen (both uncoated and dry coated). It is expected that 
for API powders in this size range, granulation may not be required and direct 
compaction may be employed for high drug loadings. The results shown here for both 
conditioned bulk density and FFC for uncoated API powder blends suggest that even for 
drug loading as high as 70 %, bulks density and FFC are above the minimum required 
values. However, similar to the blends of 20 µm dry coated ibuprofen, the conditioned 
bulk density and the FFC values are much higher than respective uncoated blends (e.g., 
50 µm uncoated 70 % API blend has bulk density of about 0.45 g/ml and FFC of about 6 
whereas dry coated API blend has bulk density of about 0.53 g/ml and FFC of well over 
10). Based on both of the bulk density and FFC values for all drug loadings, it can be 
concluded that while dry coating is not an absolute prerequisite for direct compaction, it 
will certainly improve the continuous manufacturing of high drug loading blends if 
employed. This conclusion is in agreement with the AOR test results. Further, the results 
of AOR shown in Figure 2(b) when compared to the results for the bulk density and FFC 
in Figure 3.4 indicate that the latter exhibit better discernment at various drug loading 
between uncoated and dry coated API powder blends, and hence should be more relevant 
indicators of direct compaction potential. 
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Figure 3.4 Conditioned bulk density (a) and FFC value (b) for 50 µm blends. 
Actual FFC >10 
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Compressibility is another important parameter relevant to the powder flowability 
and tabletability. Compressibility tests offer a further indication of the ability of the 
powders to pack efficiently, and is considered to have bearing to the tabletability [59]. In 
general, lower compressibility is preferred for better performance in direct compaction, 
storage in the hoppers and transportation [21]; and it has been used as a qualitative 
measure to predict tablet compactibility [59, 86]. In fact, Hausner ratio, which is a related 
measure, has been used by pharmaceutical practitioners as a guideline to predict 
performance of tablet compaction [87, 88] and capsule filling [89]. Although 
fundamental correlations between particle properties and tabletting performance remain 
elusive because of the complexity of powder behavior, as per [86], compressibility could 
provide some performance information for such as die filling, capsule filling and 
tabletting. 
The compressibility of the 20 µm blends is shown in Figure 3.5 (a). Interestingly, 
the placebo blend shows the lowest compressibility, and for low drug loading of 30 %, 
both the uncoated and dry coated curves are comparable. However, the difference 
between the compressibility of the dry coated and uncoated API blends is dramatic for 
the 60 and 70 % drug loadings, clearly showing the superior nature of dry coated API 
blends. In Figure 3.5 (b), compressibility of 50 µm uncoated and dry coated blends at all 
three drug loadings is shown along with the placebo compressibility. As may be expected, 
all API blends show lesser compressibility than 20 µm blends, although here, 30 % dry 
coated API blend exhibits slightly lower compressibility than the placebo, and all dry 
coated API blends have lower compressibility than the corresponding uncoated API 
blends.  
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Figure 3.5 Compressibility test results for (a) 20 µm blends (b) 50 µm blends. 
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These results show that dry coating can improve the compressibility of the blends 
especially for the high loading blends (60% and 70%), indicating improved potential for 
direct compaction. The compressibility results from the FT4 can be correlated with the 
tablet compaction property as will be discussed in detail in section 3.3.2. Thus based on 
the results so far on the bulk density, FFC and compressibility, it is likely that most of the 
dry coated blends may be amenable to direct compaction. The improvements due to dry 
coating may be best visualized in a plot of bulk density versus FFC as a phase map, [74, 
75], as shown in Figure 3.6. Figure 3.6(a) depicts the properties of the blends of 20 µm 
API powders, where as compared to the placebo blend, all uncoated API blends fall 
below and to the left of this point, while all dry coated API blends fall above and to the 
right of this point. Each arrow indicates the improvement for each respective drug 
loading, length of each arrow roughly indicating the extent of improvement. Each figure, 
3.6(a) and 3.6(b), shows two vertical lines, at 0.45 and 0.50 g/ml, respectively; and two 
horizontal lines, at FFC of 4 and 8, respectively, while the top rectangle is shaded to 
indicate the target regime for efficient direct compaction. The idea to be conveyed is that 
the points falling above bulk density of 0.45 g/ml and FFC of 4 are likely candidates for 
direct compaction, while those above bulk density of 0.5 g/ml and FFC of 8, hence in the 
shaded region, are excellent candidates for direct compaction for large-scale operation. 
As seen, although one is just at the boundary, all three dry coated blends fall in the 
excellent category.  Similarly, Figure 3.6(b) depicts the properties of the blends of 50 µm 
API powders, along with the arrows as well as vertical/horizontal lines and the shaded 
rectangle. As can be seen, all three dry coated blends fall well within the excellent 
category, showing that although dry coating may not be necessary for the larger, 50 µm 
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API powder blends, it would be still cost-effective to perform dry coating for a smooth 
direct compaction operation at larger scales. The suggested bulk density of 0.45 g/ml and 
FFC value of 8 are not absolute threshold values; however they provide an initial 
suggested guideline for making decision regarding the direct compaction process. For 
example, Hancock suggested a bulk density of 0.5 g/ml for ideal direct compression 
material [90]; while in (Sun, 2010), a similar guideline has been given, suggesting; 
“Avicel PH102 exhibits borderline flow properties for high speed tabletting. A powder 
exhibiting poorer flow properties than Avicel PH102 likely exhibits flow problems and 
should be avoided.” For reference, Avicel PH102 has a FFC value of 6.7 (under 9 kPa 
consolidation stress), and thus, it represents potentially a lowest acceptable value for 
flowability for powders suitable for direct compaction. It is hoped that while these are 
only the guidelines, more work within the company can lead to cut-off values based on 
their experience and type of materials they use. 
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Figure 3.6 Bulk density-FFC phase maps for 20 µm blends (a) and 50 µm blends (b). 
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When comparing the 20 µm and 50 µm API blends, it is clear that 20 µm poses a 
greater challenge for direct compaction without dry coating. Thus, it is more interesting 
to examine to what extent dry coating would improve direct compaction possibility for 
the 20 µm API blends. Therefore, in the next section, formation of tablets from selected 
cases, namely, 30% and 60% drug loading for 20 µm API blends (DC-20 and UC-20) via 
direct compaction is discussed. Another reason for selecting the micronized blends for 
tablet formation is to examine the tablet dissolution rates, which are expected to be higher 
for finer particles.  
3.3.2 Tablet Compaction and Tablet Dissolution 
3.3.2.1 Tablet Compaction 
Tensile strength profiles obtained during tablet formation in Instron of the blends of 20 
µm uncoated and FEM dry coated ibuprofen are shown in Figure 3.7. Figure 3.7(a) is for 
30% drug loading, and Figure 3.7(b) represents the 60% drug loading. The data points fit 
to the Ryshkewitch equation well (for all the cases, R
2
>0.95). The fitted mathematical 
equation of the blends tensile strength profile using Ryshkewitch equation is summarized 
in Table 3.4. Comparing the uncoated and dry coated blends, it can be observed that σ0 
increased slightly for the 30% loading dry coated blend and there is a profound increase 
(almost double the value) for the 60% loading dry coated blend.  Blend tensile strength 
profile shifts upward for the dry coated blends compared to the uncoated blends with 60% 
loading. This suggests that at the same porosity (or solid fraction), dry coated blend could 
produce harder tablet and has improved compactibility, which is desired for the tablet 
compaction. Although the dwell time was not varied in Instron tests, the results reported 
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here are representative according to Tye et al. [81], for each material, the tensile strength 
data points fall on the same general curve regardless of the dwell time. The tensile 
strength profile shifted upwards for the 60% dry coated blend, where the API powder is 
expected to dominate the bulk property, indicates that there is a substantial difference 
between the uncoated and dry coated blends, as was already observed in the bulk powder 
tests. Analysis based on the Heckel equation (equation 4) was performed to further 
explain the observed difference in tablet property, where P is the compaction pressure, D 
is the relative density (i.e., packing fraction) and K and A are constants. The reciprocal of 
K, also termed the mean yield pressure, Py, provides a quantitative measure of the 
plasticity of the material [91]; a lower Py indicates greater plasticity of a powder. 
According to [82], the greater tabletability and harder tablets are attributed to the greater 
plasticity. For all three blends, computed values of Py were lower for the dry coated 
blends; i.e., at 30 % loading, 217 MPa versus 213 MPa, at 60% loading, 370 MPa versus 
362 MPa, and at 70 % loading, 417 MPa versus 361 MPa. As may be expected, the 
difference in plasticity was higher as the API loading increased, and this may in part 
explain the differences in the tablet properties observed.  
 
 ln(1 )D KP A     (3.4) 
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Table 3.4 Estimated Parameters of σ0 and b from Equation 3 using Exponential 
Regression 
 σ0 (MPa) b 
30% UC-20 16.4 10.4 
30% DC-20 20.3 10.8 
60% UC-20 58.0 13.3 
60% DC-20 110.0 14.2 
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Figure 3.7 Tensile strength profiles for 20 µm 30% loading (a) and 60% loading (b) 
blends. 
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In addition, when comparing the tablet tensile strength profile with the 
compressibility test results from the FT4, a similar conclusion can be obtained. From 
Figure 3.5 (a), 30% drug loading uncoated and dry coated API blends show little 
difference in compressibility at 15 kPa (both about 11.8%) and there is only slight 
difference in their tensile strength profiles. On the other hand, the compressibility of 60% 
drug loading uncoated blend (25.3%) is almost double the value for the 60% dry coated 
blend (13.3%) and corresponding appreciable difference can also be observed in the 
tensile strength profiles, suggesting that the compressibility profile, which is a flow 
indicator, may also be used to qualitatively predict tablet compactibility. As mentioned 
before, although direct correlations between compressibility and tablet compactibility 
remain to be established, compressibility results could potentially provide an indication 
of the tabletting performance.  
3.3.2.1 Tablet Dissolution 
As shown in the previous section, dry coated fine, micronized APIs can be used to form 
tablets and they are amenable to direct compaction and show better performance than 
higher drug loading uncoated API blends. However, one of the major objectives of this 
chapter is to examine if dry coating helps in achieving better dissolution rates that is 
expected from fine, micronized powders. At the least, it should be ensured that dry 
coating is not hindering dissolution as compared to uncoated micronized API tablets. 
Tablets (~500 mg) made using Instron at pressure of 100 MPa were selected for tablet 
dissolution test (Table 3.5).  
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Table 3.5 Tablet Information for Dissolution Test 
 Tablet weight (mg) Porosity 
30% UC-20 Tablet 498.3 ± 0.8 0.23 ± 0.02 
30% DC-20 Tablet 498.6 ± 3.3 0.24 ± 0.02 
60% UC-20 Tablet 496.8 ± 3.7 0.28 ± 0.03 
60% DC-20 Tablet 500.9 ± 1.3 0.27 ± 0.02 
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Figure 3.8 Tablet dissolution profiles for 20 µm uncoated and dry coated tablets with  
30% loading (a) and 60% loading (b). 
 
Figure 3.8 illustrates the tablet dissolution results for 20 µm blends with 30% and 
60% drug loading. From Figure 3.8 (a), it is observed that both the uncoated and dry 
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coated API powder tablets (at lower, 30% loading) have relatively fast dissolution rate: 
however, for uncoated API powder tablet, estimated t80 (time for 80 % drug to dissolve) 
is 12 min and for dry coated API powder tablet t80 is 3 min, which is much less than what 
it took for the uncoated case. On the other hand, for higher drug loading tablets, the 
difference is more pronounced. From Figure 3.8 (b), dry coated API powder tablet has 
faster dissolution rate compared to the uncoated blend; t80 for the former is 3 min, while 
that for the latter is 55 min, thus for the dry coated case at both drug loadings have much 
faster dissolution, which is implies a nearly instant release tablet that is direct compacted. 
Also, about 92% drug was dissolved in the first 5 min for the dry coated API powder 
tablet while only a little over 80% was dissolved for the uncoated tablet in the duration of 
the test (60 min). While not shown, dissolution profiles for the 70 % API loading tablets 
were comparable to 60 % case, more importantly, dry coated ones had faster dissolution, 
with t80 well under 5 minutes. The improved dissolution for the dry coated API powder 
tablet may be attributed to lack of agglomeration in addition to fine size and the improved 
wettability from hydrophilic nano silica on the drug particle surface [72]. This is clearly 
evident since the dissolution profiles for either 30 or 60 % drug loaded tablets made from 
dry coated ibuprofen are similar, while those of uncoated are very different indicating the 
consistency in improvement due to dry coating.  
The improved dissolution may suggest that dry coating could induce some degree 
of amorphous form of ibuprofen due to mechanical stresses. In the previous study, the 
crystallinity was examined using three different methods, XRD, DSC and Raman to 
investigate this possibility. The results showed that the micronization and dry coating 
process does not change the crystallinity of ibuprofen.  
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3.4. Conclusions 
The effect of dry coating of ibuprofen powders on blends as well as tablet properties was 
investigated. It was shown that blends containing dry coated API powders, particularly 
micronized (20 µm) have improved flow, packing and compactibility compared to the 
blends containing uncoated API powders. Both the bulk density and FFC results show 
clear improvements due to the dry coating for blends made from micronized as well as 
larger ibuprofen powders with the difference between the dry coated and uncoated blends 
being more pronounced as the drug loading increased. The bulk density-FFC phase map 
for each size, clearly indicated that the overall improvement in the expected performance 
of direct compaction is greatly improved as per the proposed shaded region of high bulk 
density and excellent flow for corresponding bends. Improvements in blend 
compressibility due to dry coating, measured in the FT4, corresponded to improved tablet 
tensile strength profiles, suggesting compressibility may be used as an indicator for 
predicting tablet compactibility. The most significant advantage of dry coating is seen in 
dissolution profiles from tablets made of micronized ibuprofen powders. For all drug 
loadings, the t80 for the case of dry coated API was well under 5 min, indicating that this 
novel approach can produce nearly instant release direct compacted tablets at high drug 
loadings. Both dry coating processes, FEM based and comil based, are amenable to 
continuous and scalable operation, indicating that dry coating is a very practical approach 
to be considered for high performance manufacturing of direct compaction tablets with 
high drug loadings. The proposed bulk density-FFC based phase maps are viewed as a 
tool for developing company specific classification tool to determine suitable operations 
such as wet or dry granulation versus dry blend followed by direct compaction. Such 
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phase diagram may help in business decisions regarding added cost of dry coating, for 
instance, the shaded region, which should be fine-tuned based on existing company 
specific knowledge-base, may allow for making decisions in terms of examining the 
potential for eliminating granulation steps without extensive trial-and-error.     
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CHAPTER 4 
PASSIVATION OF HIGH SURFACE ENERGY SITES OF MILLED 
IBUPROFEN CRYSTALS VIA DRY COATING 
4.1 Introduction 
Fine particles < 30 µm have attracted significant interest from both academia and 
industry due to their high specific surface area. For instance, these particles can be used 
to improve the dissolution rate of poorly water-soluble drugs [4, 92]. The most common 
method to produce these fine particles is micronization [93], which is known to increase 
the surface energy [94] and therefore the increase of the cohesive force among particles. 
Ultimately, this high surface energy contributes to the formation of solid bridging, 
agglomeration, poor flow and low bulk density [95-98]. As a result, handling and 
processing of these fine powders in dry state is difficult.  
The poor flowability of fine powders, both the active pharmaceutical ingredient 
(API) and excipients, is a well known problem in the pharmaceutical industry. It is well 
documented that good flowability is necessary for the successful manufacture of 
pharmaceutical products [18]. For example, in the production of tablets through direct 
compression, poor powder flow can lead to large variations in tablet weight or tablet 
content uniformity. Besides developing formulations with large amount of excipients 
with good flow characteristics, several other methods have been developed to improve 
the flowability of the powders [41], which mostly involve polymer thin film coating of 
particles [30] or granulation [40, 99, 100] and require either solvents and/or multiple 
processing steps and long processing time. Previous studies performed by the authors’ 
group have shown that surface modification by dry particle coating is an effective and 
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simple method of improving the flowability of the powders without using solvents or 
granulation [31, 32, 34, 74].  
In dry particle coating, ultra-fine guest particles are uniformly dispersed over the 
surface of host or carrier particles in order to enhance the property of the host material, 
most common example being its flow. Although flow enhancement can be easily 
obtained through blending with flow additives, it has been shown that dry coating devices 
[33], which involve high level of impacts and/or shear, lead to uniform dispersion of 
guest nano-particles rather than sparse, inefficient coating expected when flow additives 
are blended using conventional mixers [32]. Various host materials including 
pharmaceutical powders (excipients and APIs), and different types of guest materials 
(silica, alumina, titania, talc, MgSt, leucine, carbon black, etc.) have been considered and 
it was shown that enhanced powder properties such as flowability, bulk density, reduced 
electrostatics, and dispersibility, were obtained compared to both uncoated powders and 
powders simply blended with the guest material in a conventional mixer [31-35]. Main 
mechanisms of flow enhancement through dry coating have also been investigated, and it 
has been shown using a single asperity model validated by experiments that (a) flow 
improvement is due to the cohesion that is reduced due to decreased van der Waal’s 
attraction between two host particles, and (b) cohesion reduction is inversely proportional 
to the guest particle size [32].  An advanced multiple-asperity model taking into account 
the effect of the surface area coverage (SAC) of the coated nano-sized particles has also 
been developed to better predict the effect of dry coating on the cohesion reduction [29], 
where it was shown that a minimum SAC of 20 %, and more preferably, about 40 % is 
required to eliminate host-host and host-guest contacts [36]. It was also shown that 
92 
 
 
 
optimal guest size is in the range of 10-20 nm, and the SAC should not be over 100 % for 
ensuring optimal level of cohesion reduction. Overall, such models show that the 
presence of nano-sized guest particles can influence both the surface roughness (modifies 
the contact radius and area between particles) and the surface energy (modifies the 
strength of interaction), which will reduce the cohesive force among the coated particles 
and ultimately improve the bulk powder behavior [29, 32, 34, 36-38].   
Two types of the dry coating techniques have been proposed to address the flow 
related problem: (1) dry coating without affecting the particle size of the host powder 
(type-1) and (2) simultaneous micronization and surface modification (type-2) to mitigate 
the disadvantage of the poor bulk properties of the micronized powder. The latter is more 
relevant for fine pharmaceutical powders which are usually produced via milling or 
micronization, for which, it has been shown that simultaneous micronization and dry 
coating can be achieved by the Fluid Energy Milling (FEM) process [72], eliminating a 
separate type-1 dry coating process. In the previous study, 5 and 10 µm micronized and 
dry coated ibuprofen powders processed in the FEM exhibited excellent dispersibility, 
improved flow and dissolution behavior over the as received powder. The uncoated 
micronized powders, on the other hand, showed poor dispersibility, flow and dissolution 
behavior, as well as severe electrostatic charging. For both type -1 and type-2 dry coating 
methods, an improvement of the bulk properties was observed for the surface modified 
powders. The improvement was explained in terms of the reduced cohesive force 
introduced by the surface modification. Although the effects of particle size and surface 
roughness on different bulk properties were previously investigated [32, 71, 101], a 
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systematic and in-depth investigation of the influence of dry coating (discrete coating) on 
surface energy of milled pharmaceutical crystals has yet to be performed. 
Surface energetics estimations [102, 103] have been used to understand the 
various pharmaceutical interactions, such as predicting wettability [104] and influence of 
formulations, the interaction of drugs in dosage form [105, 106], stability, bioavailability 
of drug powders [107], powder dispersion in aqueous media or non-aqueous media [108], 
or to explain the  adhering property of powder to the wall of the container [109]. Surface 
energy is also used to predict the disintegration and dissolution of solid dosage forms, 
film coating of granules or tablets [110], etc. Also, the parameters like spreading 
coefficients or reduced spreading coefficient, which are a function of surface energy, 
have been used to predict the aggregation of powders dispersed in aqueous suspension 
[108]. Additionally, the surface energy is well known to significantly impact processing 
and formulation characteristics due to its effect on the bulk powder behaviors [111] such 
as powder flow [112], bulk density [98] and the performance of dry powder inhalers [97]. 
Pharmaceutical materials are known to have heterogeneous surfaces, imperfections and 
impurities, leading in many cases to high surface energy and difficulty in its predictions 
[102]. In fact, micronization is known to increase the heterogeneity of pharmaceutical 
materials by introducing high energy sites [93, 113] due to crystal defects [114] and 
exposing different crystal habits [115]. These high energy sites and heterogeneity will 
ultimately affect the quality and performance of the final product [94, 112]. Traditional 
techniques for accessing surface energy of powders have been through liquid penetration 
and contact angle measurements, which suffer from practical and/or theoretical 
limitations, and are not suitable for powders according to Buckton et al.[116].   Two 
94 
 
 
 
alternative approaches have been proposed; microcalorimetry [107] and dielectric 
spectroscopy [117], both of which are based on evaluation of the interaction between the 
powder and vapor. More recently, the use of inverse gas chromatography (IGC) has 
become a popular tool for evaluation of surface energy [93]. Recent studies using IGC 
have shown that surface energy reduction through type-1 dry coating can lead to flow 
improvements. Jallo et al. showed flow improvements due to the reduced surface energy 
of micron-sized aluminum particles by type-1 dry coating with nano-sized silica [35]. For 
the case of type-2 dry coating, where micronization is employed [72], the influence of the 
dry coating material on the high energy sites created during micronization has not been 
investigated. Clearly, as reported [72], dry coating improves flow and reduces cohesion, 
which may be explained in part via reduced overall surface energy. However, it would be 
interesting to examine its influence on the heterogeneity of the milled surface. 
Consequently, the effect of dry coating on the surface energy and heterogeneity of the 
surface energy on the host powders prepared in type-2 dry coating technique is the main 
purpose of the present study.  
In this work, the effect of micronization and simultaneous dry coating on the 
powder properties of milled ibuprofen will be investigated. The study consists of two 
major components; in the first one, ibuprofen crystals are milled to various median sizes 
in the range of 5-28 µm to investigate the influence of particle sizes and dry coating on 
the bulk properties. Dry coating parameters, including the type and amount of nano-silica 
are determined based on previous work, including the models for cohesion reduction [29, 
32, 34, 36-38]. It will be shown that dry coating significantly improves powder flow 
properties, such as flowability, dispersibility, bulk density and unconfined yield strength, 
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as anticipated by a previous study [72]. Thus it will be shown that surface modification 
may be useful in mitigating usual disadvantages of micronization by simultaneously dry 
coating the fine ibuprofen powders during the milling process. In the second part, which 
is the major novel contribution of this study, the influence of particle size and the 
micronization process itself on the surface energy will be examined with or without dry 
coating. The surface energy is measured by inverse gas chromatography (IGC) to 
examine the surface energy heterogeneity due to milling, with or without dry coating. 
This will allow for answering questions such as: (1) Does surface energy correlate with 
bulk properties of micronized ibuprofen powders? (2) Can dry coating reduce the surface 
energy of micronized powders and hence improve their bulk properties? (3) Can the high 
energy sites of highly heterogeneous milled ibuprofen be quenched, and hence stabilized 
through dry coating for reducing the surface energy heterogeneity?  It is hoped that 
answers to such questions will help in improving the outcome of micronization of 
pharmaceutical crystals.    
4.2 Experimental 
 
4.2.1 Materials 
Ibuprofen 50 was purchased from BASF (NY, USA). Median particle size (d50) is 58 m. 
The dry coating material was amorphous hydrophilic nano-silica (M5-P, pharmaceutical 
grade, Cabot Corporation, MA) and hydrophobic nano-silica TS530 (Cabot Corporation, 
MA), having the BET surface area of 200 and 212 m
2
/g, respectively [118]. Decane, 
nonane, octane, hexane, heptanes, dichloromethane and ethyl acetate were used as probes 
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in the IGC. All the probe solvents were HPLC grade and purchased from Sigma–Aldrich, 
USA.  
4.2.2 Preparation of Dry Coated and Uncoated Samples 
The simultaneous micronization and dry coating process involved two steps. First the 
ibuprofen powder was pre-mixed with nano-silica in a v-shaped blender, which was then 
followed by milling in the fluid energy mill (FEM). The method has been previously 
reported [72] and will be only briefly described below. The desired amount of ibuprofen 
and nano-silica were pre-mixed in a 6 quart V-shaped blender (VB, Patterson-Kelley, PA, 
USA) with the intensifier bar. The V-blender was operated at 25 rpm with the intensifier 
bar rotating at 3600 rpm for 10 minutes. The V-blender was continued for another 20 
minutes without the intensifier bar.  
 Simultaneous micronization and dry coating was realized through FEM processing 
as following. The pre-mixed powder was fed into the FEM unit (Sturtevant Inc., Hanover, 
MA) using a Schenck Accurate volumetric feeder (Whitewater, WI), which was 
calibrated before each experiment. The pre-mixed powder was fed into the FEM through 
a feed funnel aided by a venturi based feeding air inlet. High velocity gas introduced by 
the two grinding air inlets induces particle-particle and particle-wall collisions, which 
results in both particle breakage and dispersion of the nano-sized guest particles onto the 
newly created surfaces. As the particle size was reduced, the drag force exerted by the 
exiting air is able to overcome the centrifugal force felt by the particle and then it carries 
the powder from the milling chamber to the collecting jar. Simultaneously micronized 
and dry coated API particles were produced at different sizes by controlling the solid 
feeding rate, feeding pressure and grinding pressure.  
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 To produce pure, or un-coated, micronized powder of a comparable size, a similar 
procedure was used without the addition of the nano-silica or a pre-mixing step. 
Processed samples were stored in vacuum desiccators at room temperature, while 
characterization was done at room temperature of 60-65 °F and relative humidity (RH) of 
30-40% within 24 hours.   
4.2.3 Powder Characterization 
a. Particle size measurement 
Volume based particle size distribution of the powders was measured by Rodos/Helos 
system, which was described in Chapter 2. Size statistics of d10, d50 and d90 at dispersion 
pressure of 0.5 bar are reported (Table 4.1). Experiments were also conducted at different 
dispersion pressures starting at 0.2 bar to 2.0 bar, hereafter called pressure titration tests, 
which were performed by a series of size measurements at different dispersion pressure 
to test the dispersibility of the powders.  
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Table 4.1 Particle Size Distribution Data for as Received Ibuprofen and FEM Processed 
Dry Coated and Uncoated Powders 
  d10 (µm) d50 (µm) d90 (µm) 
As received IBU 50 16.1 57.9 146.7 
UC-IBU-5 1.3 4.6 9.9 
UC-IBU-10 3.0 11.7 11.9 
UC-IBU-15 6.4 14.4 28.8 
UC-IBU-20 6.0 20.7 48.2 
UC-IBU-28 7.1 27.4 69.4 
M5P-DC-IBU-5 1.7 5.5 11.9 
M5P-DC-IBU-10 3.5 10.9 21.5 
M5P-DC-IBU-15 3.9 15.0 29.6 
M5P-DC-IBU-20 2.7 19.1 48.2 
M5P-DC-IBU-28 5.4 26.6 67.1 
TS530-DC-IBU-5 1.7 6.9 14.8 
TS530-DC-IBU-10 3.3 10.6 20.4 
TS530-DC-IBU-15 6.1 14.9 29.8 
TS530-DC-IBU-20 9.2 19.8 35.5 
TS530-DC-IBU-28 9.2 28.3 74.0 
 
b. Scanning Electron Microscope (SEM) 
Particle morphology of particles was examined using a Field Emission Scanning Electron 
Microscope (FESEM) (LEO 1530 170, Carl Zeiss SMT Inc.)  All the powder samples 
were pre-coated with carbon by sputter coater to enhance conductivity under FESEM. 
c. Powder characterization using FT4 powder rheometer 
A detailed description of FT4 powder rheometer can be found in Chapter 2, section 2.2.3. 
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All the samples were tested multiple times and average values along with error bars were 
reported. 
d. Surface energy measurement using Inverse Gas Chromatography (IGC) 
Surface energy measurements were carried out using an automated inverse gas 
chromatograph (IGC 2000, Surface Measurement Systems Ltd., Middlesex, UK) 
equipped with a flame ionization detector (FID). Compressed methane (SOS Gases, Inc) 
was used as the reference gas, helium (SOS Gases, Inc) was used as the carrier gas with 
hydrogen (SOS Gases, Inc) and compressed air employed for the FID. 
The surface energy of all the powders and the two types of the nano-sized silica 
was measured at probe coverage of 0.5% (i.e., 0.5% of the surface sites were sampled) to 
determine the influence of the highest energy sites. The surface energy heterogeneity of 
selected samples was characterized by using multiple probe coverage ranging from 0.5% 
to 12%. Decane, nonane, octane, hexane and heptane were used as non-polar probes; 
dichloromethane and ethyl acetate were used as polar probes. Samples were prepared for 
surface energy measurement by loading approximately 350 mg of the coated or uncoated 
powder sample into presilanized glass columns (300 × 4 mm i.d.). The sample columns 
were loosely blocked with silanized glass wool at both ends and tapped until no cracks or 
channels were visible in the powder bed. The sample column was conditioned for 1 h at 
30 °C in flowing helium before each measurement to remove impurities adsorbed onto 
the surface. Probes were carried into the column by helium with a gas flow rate of 10 
sccm (standard cubic centimeter per minute), and the retention time was detected by a 
flame ionization detector. The dead volume was calculated based on the elution time of 
methane. The dispersive surface energy was calculated according to the Schultz method 
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[119] and the polar surface energy was calculated according to Good-van Oss method 
[120]. The dispersive surface energy distribution profiles were determined according to 
the method described by Yl -M ih niemi et al. [121]. Adsorption measurements were 
performed at 30 °C and 0 % RH. Each sample was tested multiple times and the average 
value was reported.   
  
4.3 Results and Discussion 
The bulk and material characteristics of a series of FEM processed ibuprofen powders are 
discussed in this section. Ibuprofen 50 with a starting size of 58 µm was micronized with 
and without silica nanoparticles to investigate the influence of micronized size, dry 
coating and the micronization process itself on the bulk powder properties and surface 
energetics of the product powder. This was achieved by starting with representative SEM 
images to illustrate particle morphology and confirm the presence of nano-silica particles 
in the form of surface modification for the dry coated samples. This was followed by a 
discussion of the effect of micronization and dry coating process on the bulk properties, 
and finally a discussion of the results of micronization and dry coating on the surface 
energetics and their importance to the bulk properties.  
To investigate the influence of particle size, the micronization process and dry 
coating, the micronization conditions were adjusted to produce uncoated and surface 
modified powders with matching volume averaged median sizes (d50). Five sets of these 
powders were produced with nominal sizes of 5, 10, 15, 20 and 28 µm. The sizes of the 
as received and micronized powders are listed in Table 4.1, and corresponding volume 
based cumulative particle size distributions (PSD) are presented in Figure 4.1. Figure 4.1 
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shows how the PSD may change from right (the starting material) to left as the milling 
intensity is increased.   
 
Figure 4.1 Volume based particle size distribution for as received and TS530 dry coated 
and milled ibuprofen with size in the range of 5-28 µm. 
 
Representative SEM images of the uncoated and two types of silica coated 
ibuprofen powders with the nominal sizes of 28, 15 and 5 µm are shown in Figure 4.2. 
Images in Figure 4.2 a-c show the changing morphology with decreasing particle size 
from somewhat rod/flake like shapes to spherical shape for the uncoated micronized 
ibuprofen. The uncoated micronized powders (Figure 4.2 a-c) show a tendency to 
agglomerate and in many cases the formation of solid bridges can be observed. It is 
hypothesized that it is the high energy sites introduced from the micronization process 
resulting in severe agglomeration and in some cases the solid bridging as shown in Figure 
4.2 a-c. This solid bridging phenomenon may be attributed to mechanical milling, which 
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could increase the defect concentration on the surface, or the surface energy, leading to 
faster sintering because of faster diffusion [122]. This may be further explained through 
surface energy measurements as will be discussed in the later section. These SEM results 
concur with the literature and previous study that micronization process can lead to 
strong inter-particle cohesion which will result in severe agglomeration [14, 15, 72]. In 
contrast, the dry coated powders (Figure 4.2 d-f) are not agglomerated due to the 
presence of nano-silica on the surface. Their presence appears to prevent interactions 
between the host particles even at the low surface coverage by silica, depicted in Figure 
4.2 d-f, resulting in less agglomeration, possibly due to reduced cohesion as predicted by 
previous work [34, 84]. The reduced agglomeration is expected to lead to improved flow 
properties [35, 72, 101]. Images in Figure 4.2 g-h show dry coating of hydrophilic (M5P) 
and hydrophobic (TS530) silica respectively for the finest milled ibuprofen. Our aim is to 
examine if nano-sized silica coating on the surface can not only act as nano-sized 
asperities that lead to reduced cohesion [32] but also cover these high energy sites, thus 
preventing the formation of solid bridges and agglomeration. The changes in size, shape, 
surface energy and surface roughness after micronization with or without dry coating are 
all expected to affect both the bulk and particle characteristics of these powders, which 
are examined subsequently. 
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Figure 4.2 SEM images of ibuprofen samples: (a-c) uncoated ibuprofen, 28 µm, 15 µm 
and 5 µm, (d-f) silica M5P coated ibuprofen, 28 µm, 15 µm and 5 µm, (g) M5P coated 
ibuprofen 5 µm, (h) TS530 coated ibuprofen 5 µm. 
 
4.3.1 Bulk Level Characteristics 
The flow behavior of a bulk solid cannot be described by a single characterization 
method and is best described by several well-defined parameters [21, 52, 57, 85]. The 
methods used in this work are the dispersibility, bulk density, compressibility and 
unconfined yield strength.  
It has been shown previously that the particle size distributions from dispersion 
pressure titration obtained from the Rodos/Helos particle size analyzer could be a good 
indicator of powder dispersibility [72, 101]. The pressure titration is commonly used to 
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determine the minimum dispersion pressure necessary to break up agglomerates and 
measure the size of the primary particles by comparing the measured d90 particle size of 
the dry powders. It has also been used successfully as a means to assess the extent and 
efficacy of fine particle coatings in a dry powder process [123]. As the dispersion 
pressure is increased from a low value, first, the powders are deagglomerated to primary 
particles, and then further increases can eventually lead to primary particle attrition. The 
region between deagglomeration and attrition is considered the stable region, which is 
ideal for measuring particle sizes, and it may also indicate how dispersible the powder is; 
the larger the stable region, the more dispersible the powder. In general, however, the 
dispersibility of a powder can be derived by comparing the slope of the plot of the 
particle size with respect to dispersion pressure, where smaller absolute slopes indicate 
better dispersibility and larger ones indicate worse dispersibility [64]. The pressure 
titrations of the 5 µm uncoated and dry coated ibuprofen samples are shown in Figure 4.3 
as an example; since finest powders are expected to be more cohesive and agglomerated. 
A sharp drop in the d90 size (from over 150 µm to about 10 µm) can be observed for the 
uncoated micronized powder (UC-IBU-5) with increasing dispersion pressure, indicating 
poor dispersibility. This drastic change in the measured particle size is due to the 
breaking down of large agglomerates of the micronized particles at higher dispersion 
pressures. The pressure titration results of the micronized and dry coated powders (either 
hydrophobic silica coating TS530-DC-IBU-5 or hydrophilic silica coating M5P-DC-IBU-
5) show very different trends. These powders have nearly zero slopes, and the size 
change from the lowest to highest dispersion pressure is about 1 µm for M5P coated 
powder, and is only a fraction of 1 µm for TS530, indicating that the powders require less 
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energy, hence, lesser pressure to be dispersed and thus have excellent dispersibility. 
These results also qualitatively agree with the SEM images shown in Figure 4.2, which 
depicted severe agglomeration and solid bridging for the uncoated powders, whereas well 
dispersed primary particles after dry coating. In summary, it is evident from the results in 
Figure 4.3 that there is a clear difference in the dispersibility between the micronized 
ibuprofen powders with and without silica coating.  
 
Figure  4.3 Pressure titration results of d90 values for 5 µm ibuprofen samples, with and 
without dry coating with M5P or TS530 silica. 
 
Bulk density is considered as one of the critical properties in handling, storage 
and processing powders, where higher values typically indicate better packing and flow 
[85]. With this in mind, the bulk densities of the uncoated and surface modified ibuprofen 
powders have been characterized. Because of its greater repeatability, the conditioned 
bulk density of the uncoated and dry coated powders were measured and are plotted as a 
function of particle size as shown in Figure 4.4 [57, 71, 75]. It can be seen that the bulk 
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density for all of the powders generally increase with increasing particle size, but the 
surface modified powders have substantially higher bulk densities than their uncoated 
counterparts. In addition, it can be seen that hydrophobic nano-silica (TS530) coated 
powders have higher bulk density than the hydrophilic (M5P) coated ones; in particular, 
the difference is very significant for smaller particles, suggesting that the hydrophobic 
silica drastically reduces cohesion and improves packing. It is likely that the difference in 
these properties stems from the more effective coating of the hydrophobic silica as 
compared to hydrophobilic silica, which can be seen in the SEM images shown in Figure 
4.2g and 4.2h. As can be seen, the amount of TS530 silica is higher (see Figure 4.2h) than 
M5P silica (see Figure 4.2g) on the ibuprofen surface, suggesting better dispersion and 
coating, and hence better bulk properties, including the bulk density. For the dry coated 
powders, the bulk density steadily increases with increasing particle size, whereas, the 
uncoated powders show a more erratic behavior. This may be attributed to the highly 
cohesive nature of the uncoated powders, resulting in formation of agglomerates and 
solid bridges, which leads to reduced ability to efficiently rearrange during the 
conditioning process and leading to variability in the measurements. From these results, it 
can be concluded that dry coating greatly improves the bulk density, which is attributed 
to the reduced cohesive force among the dry coated particles. Reduction in the cohesion 
force will be examined via analyzing the results from shear testing, and reported in terms 
of the unconfined yield strength of the powder bed. 
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Figure 4.4 Conditioned bulk density vs. median particle size for uncoated, and dry coated 
with either M5P or TS530 silica, of ibuprofen powders. 
 
Compressibility tests offer a further understanding of the ability of the powders to 
pack efficiently, and is considered to have some bearing to the tabletability [59]. 
Compressibility is a measure of how density changes as a function of applied normal 
stress and is important for the storage, handling and transportation of the powders [54]. 
Usually a lower compressibility is preferred, which is an indication of efficient packing 
among the particles and minimal excess air in the bulk. Fine powders typically have high 
compressibility due to their high relative cohesion, implying powder will only rearrange 
when significant pressure is applied to force rearrangement of the particles; well flowing 
powders with less cohesion will readily rearrange under their own weight, resulting in 
high bulk densities (as discussed above) and low compressibility values. The 
compressibility of the uncoated and dry coated ibuprofen powders was evaluated and the 
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results are shown in Figure 4.5. The compressibility of the dry coated powders were 
markedly lower, 24% and less, in contrast to about 40% for their uncoated counterparts, 
indicating that they are less cohesive and have comparable bulk densities after 
conditioning and after compression at 15kPa. The compressibility of the uncoated powder 
is very high and interestingly, does not show any particular trend with increasing particle 
size, which may be attributed to the severe agglomeration of the uncoated particles at all 
particle size range (as may be seen in the SEM images, and also indicated in Figure 4.3 
for the finest grade). Similarly, the error bars for the uncoated powders are larger, and the 
large scatter coincides with what was observed in the bulk density results.  
 
 
Figure 4.5 Compressibility vs. median particle size. 
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The unconfined yield strength (UYS) is the compressive strength or cohesive 
strength of the powder [57, 59], which is caused by the cohesive forces acting between 
the particles. The UYS is an important parameter regarding the powder flow (i.e., the 
most important parameter relating to prediction of the arching and minimum hopper 
outlet) [59]. According to Molerus [124], the UYS is proportional to the cohesive force 
(at unconsolidated state) and inversely proportional to the square of the particle size 
(Equation 1), hence it is a direct measure of the cohesive nature of the particles. Figure 6 
shows the unconfined yield strength of the uncoated and dry coated powders as a function 
of particle size. From the figure, it can be seen that the UYS of the dry coated samples are 
almost an order of magnitude lower than their uncoated counterparts. The error bars for 
the UYS of several points for uncoated powders are very large and so is the scatter, 
whereas dry coated powders exhibit less scatter and smooth trends. UYS can give direct 
indication of the inter-particle adhesion as per Equation 4.1. Accordingly, for samples 
having the same particle size, the dry coated samples have significantly lower inter-
particle cohesion than the uncoated counterparts. Although the UYS for all the powders 
reduces as the particle size gets larger, the dry coated powders exhibit low values even 
for the smallest sizes, indicating it is very effective at reducing cohesion.  
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Figure 4.6 Unconfined yield strength vs. median particle size. 
 
 
2
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  (4.1) 
  
Micronization processes are known to expose higher energy sites on the particle 
surface, leading to stronger inter-particulate cohesion. Furthermore, particles micronized 
to smaller sizes have a larger proportion of newly exposed surface and thus likely to have 
a larger proportion of exposed high energy sites. In the case of the dry coated powders, 
the guest particles are expected to cover the high surface energy sites, and the cohesion 
properties will be defined by the nano-silica and not the micronized particle, given there 
is a sufficient surface coverage [29, 36]. This is because the force of attraction between 
two surfaces is primarily a function of their material property, such as surface energy or 
Hamaker constant and contact radius [29, 35, 36], and coating by nano-silica is expected 
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to influence both. Therefore the force required to fracture the powder bed consisting of 
dry coated powder is reduced and is defined primarily by the coating material and is less 
affected by the size or micronization parameters than the uncoated powders.  Although 
the values of the more popular flow indicator flow function coefficient (FFC, the ratio of 
consolidation stress to the unconfined yield stress) from the shear test of the samples are 
not presented here, naturally they had similar trend as the UYS.  
The results in this section demonstrate that after micronization, the flowability, 
indicated via UYS, of the uncoated samples becomes worse as the particle size gets 
smaller. However, this is mitigated through dry coating; which also leads to improvement 
of other bulk properties such as dispersibility, bulk density, and compressibility, all of 
which are due to the reduced cohesive force among the dry coated particles. Since the 
inter-particle cohesion force is directly proportional to the surface energy [27, 28, 125], in 
the next section, the influence of micronization and dry coating on the surface energy will 
be investigated through IGC measurements with a purpose of explaining the observed 
trends in the bulk properties.  
4.3.2 Particle Scale Characteristics 
In this section, the surface energy of the micronized and dry coated powders, especially 
the dispersive component, which relates to the cohesion, will be examined to explain the 
observed flow improvements after dry coating and to study the role of dry coating on the 
surface energy. Additionally, powder x-ray diffraction is also carried out to assess the 
impact of micronization and dry coating on the crystallinity of the processed drug powder 
and it is presented first.   
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The crystallinity of a pharmaceutical substance has an effect on its physical and 
chemical stability. Most of the pharmaceutical products are formulated to contain drug in 
the stable crystalline form for the sake of long-term stability. For the FEM process, it is 
possible that high level of mechanical stress may lead to change in the form of the drug. 
Therefore the effect of FEM process on crystallinity is evaluated. XRD measurements 
were done for the finest size, which undergoes the highest level of mechanical stresses. 
The results, presented in Figure 4.7, show that as received and freshly processed 
ibuprofen powders (UC-IBU-5 and M5P-DC-IBU-5) have nearly the same patterns and 
peak positions. This suggests that the micronization process does not induce a 
polymorphic transition or amorphization of the model drug, ibuprofen, used in this study. 
These results agree with the pervious study, where it was shown from XRD, as well as 
differential scanning calorimetry (DSC) and Raman spectroscopy, that micronization in 
the FEM with or without dry coating does not change the crystallinity [72]. Similar 
results were obtained in Jain et al. [126], where jet mill was utilized to micronize 
fenofibrate, and it was found using the DSC method that the crystallinity was not 
changed after the micronization process.  
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Figure 4.7 XRD spectrum results for as received (AR-IBU50), micronized to 5 μm 
without coating (UC-IBU-5) and micronized to 5 μm with dry coating (M5P-DC-IBU-5) 
samples. 
 
The surface energy values of the uncoated and dry coated powders are shown in 
Figure 4.8 a. These values, have the biggest influence on cohesion, were measured at 
fractional probe coverage of 0.5% (0.5% of the surface sites were sampled), which 
corresponds to their attachment to the most energetic sites. Typically the IGC probes 
preferentially interact with the higher energy sites, resulting in high measured surface 
energy values at low fractional probe coverage [127]. The surface energies of crystalline 
APIs, like ibuprofen, are known to increase as they get finer as a result of micronization, 
which is often attributed to the revealing of higher energy crystal planes [94, 121, 128] or 
the generation of crystal defects [114]. As seen in the figure, the surface energy of the 
uncoated samples increased nearly linearly with decreasing particle size (increased 
micronization), which is expected. On the other hand, the surface energies of the dry 
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coated samples are nearly invariant and are very close to the surface energies of the as 
received nano-silica particles (values are in Table 4.2, also shown by two dashed 
horizontal lines in Figure 4.8 a, the lower of the two lines is that of TS530, whereas the 
higher line is that of M5P). These results indicate that the high energy sites produced in 
the micronization process are covered or “quenched”, hence passivated by the nano-sized 
silica particles, leading to no significant increase as was the case for uncoated powders, 
thus reducing the cohesion of the coated micronized particles. The general trends 
observed in Figure 4.8 a are similar to those for UYS shown in Figure 4.6 and thus 
confirm that the cohesion of the dry coated powders was reduced and are mostly 
controlled by the properties of the coating materials. Additionally, nano-sized silica 
particles cover the high energy sites, and thus also reduce the driving force of sintering 
and hence deactivating it. That may explain why the dry coated samples are well 
dispersed and there are no solid bridges observed in the SEM images. The influence of 
dry coating on altering surface properties has been shown in previous study [129, 130], 
where dry coating by nano-sized silica was used to increase the sintering temperature, 
thus reducing the sintering rate of glass beads, PMMA and γ-alumina. In the current work, 
dry coating appears to prevent aggregation that is based on sintering or solid bridging. 
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(a)  
 
(b) 
 
Figure 4.8 Dispersive surface energy results of (a) uncoated, M5P and TS 530 silica dry 
coated ibuprofen with different sizes and (b) 5 µm ibuprofen samples before and after 
surface modification via FEM (All at 0.5% fractional coverage). 
 
116 
 
 
 
One question that may arise when using method such as inverse gas 
chromatography is that if the total surface area of one of the constituents, e.g., the silica 
particles is very large compared to the other constituent, e.g., ibuprofen, then the results 
may be biased by the property of the silica that has high surface area. While the 
procedure employed in the instrument we have used takes care of such issues, we 
consider a more detailed assessment of the effect of micronization and dry coating, along 
with presence of silica in the mixture or on the surface of the ibuprofen. Accordingly, the 
surface energy results of ibuprofen for various cases are shown in Figure 4.8 b. The 
results are those of as-received ibuprofen (58 µm), micronized uncoated ibuprofen (5 
µm), micronized and dry coated ibuprofen (5 µm) and a simple physical mixture (labeled 
as “mixture”) of micronized ibuprofen (5 µm) and nano-silica. In this figure, cartoons are 
included to illustrate the nature of each sample, highlighting the differences in size and 
surface coating state for each sample, especially for the silica dry coated sample and the 
physical mixture of ibuprofen and silica. Here the physical mixture is obtained by just 
gently combining proper amounts of uncoated ibuprofen and nano-sized silica without 
use of any mixing device. It can be observed that the as-received ibuprofen has a surface 
energy of 29.9 mJ/m
2
. When micronized to 5 µm without dry coating, the surface energy 
increased drastically to 54.4 mJ/m
2
, confirming that the micronization process had indeed 
created or opened up new high energy sites. On the other hand, the surface energy of the 
simultaneously micronized and dry coated samples had only increased slightly (37.5 
mJ/m
2 
for M5P dry coated and 35.7 mJ/m
2 
for TS530 dry coated). These values obtained 
are comparable to the surface energies of the nano-silica particles (see Table 4.2), 
confirming both their presence on the surface of the micronized ibuprofen and their 
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covering the ibuprofen high energy sites. As a control, the surface energy of the 
micronized uncoated ibuprofen (UC-IBU-5), gently mixed with TS530 nano-silica, i.e, a 
physical mixture, was measured to understand the influence of the silica without it being 
dry coated. The physical mixture had a surface energy of 53.5 mJ/m
2
, which is 
comparable to the uncoated sample (54.4 mJ/m
2
), the reduction being the contribution of 
small amount of silica (6.6 wt% in the sample tested
2
), which is present in the physical 
mixture, but not “covering” the high energy sites on ibuprofen powders. This indicates 
that during the surface modification, silica intimately interacts with the ibuprofen surface 
and quenches the high energy sites and that the surface energy measurement is not merely 
biased by the presence of the silica that has very high surface area. Furthermore, these 
results show that the simple presence of silica, in the form of a physical mixture, is 
ineffective at reducing surface energy and hence ineffective at improving the bulk 
properties as was reported previously [32]. These results emphasize the importance of dry 
coating and not simply adding flow aids like silica in the improvement of both bulk and 
particle properties of the powders. 
  
                                                             
2
 Weighted average of the surface energies of uncoated ibuprofen and silica yield a value close to 
53.1 mJ/m
2
, which is comparable to the measured value of 53.5 mJ/m
2
. 
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Table 4.2 Surface Energy of as Received Host Material, Guest Materials and Uncoated 5 
µm ibuprofen 
 Dispersive surface energy 
(mJ/m2) 
Polar surface energy 
(mJ/m2) 
Ibuprofen 50 29.9 5.5 
UC-IBU-5 54.4 4.7 
Silica M5P 36.5 21.2 
Silica TS530 34.1 2.0 
 
 It is noted that in the present study, the main goal is to identify the effect of dry 
coating on the as processed micronized samples, hence the surface energy measurements 
were performed without subjecting the samples to any conditioning or aging. It has been 
reported that sample conditioning at different humidity has an influence on surface 
energy. For the dispersive component of the surface energy, it was found that usually it 
decreases or remains unchanged with an increase in RH [131-133]. For the polar 
component of the surface energy, it was found that it either increases [134] or decreases 
[131, 135]. Although it would be interesting to examine how dry coated sample are 
affected by conditioning or aging in contrast to un-coated samples, it is not within the 
scope of the present study and may be addressed in future. 
Now that the surface energy measurements are available, an explanation for the 
difference seen between the extent of coating of TS530 and M5P silica, shown in Figures 
4.1g and 4.1h, may be considered based on the surface energy values. Rowe [106] 
defined a reduced spreading coefficient which is synonymous to the ratio of the work of 
adhesion to cohesion. The reduced spreading coefficients of two types of silica on the 
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host ibuprofen particles are calculated according to Rowe’s equation (equation 4.2), 
which takes the surface energy values into account. In equation 4.2, 
B/Aλr denotes the 
spreading coefficient of material B onto material A; γd is the dispersive surface energy, γp 
is the polar surface energy and 
Bγ is the total surface energy of material B. Taking 5 µm 
ibuprofen as an example (Table 4.2, and Figures 4.2 g and 4.2 h), the spreading 
coefficient of silica M5P onto ibuprofen λM5P/IBU is estimated as 0.89; and the spreading 
coefficient of silica TS530 onto ibuprofen λTS530/IBU is estimated as 1.24. According to 
Rowe [106], complete spreading will occur when λ ≥ 1. This may explain improved 
TS530 silica coating as compared to the M5P silica coating seen in Figures 4.2 g and 4.2 
h, and hence the packing of TS530 silica coated ibuprofen is better. 
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Next, surface energy measurements were performed at different fractional probe 
coverage, ranging from 0.5% to 12%, on the micronized uncoated and dry coated 
powders to examine the surface energy heterogeneity. Typically, the IGC probes 
preferentially interact with the higher energy sites over lower energy sites.  By measuring 
the surface energy at higher fractional probe coverage a larger portion of the particle 
surface can be evaluated, potentially accessing lower energy sites [136]. It is expected 
that significant variation in the measured surface energy with respect to fractional probe 
coverage is an indication of a heterogeneous surface energy distribution.  
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Figure 4.9 illustrates the surface energy heterogeneity results for three examples 
with 5, 15, and 28 µm in size (uncoated and dry coated). For all three cases, the uncoated 
ibuprofen shows a decreasing surface energy profile with increasing fractional probe 
coverage, indicating that the surface energy distribution of the uncoated micronized 
ibuprofen is heterogeneous, containing both high and low energy sites. The effect of the 
intensity of the micronization process can also be seen in the differences in the curves of 
the uncoated powders: the extent of the drop, or the slope of the surface energy curve is 
greater for the 5 µm particles than the 15 µm particles, which is greater than the 28 µm 
particles. This is a clear indication that as milling becomes more intense, it leads to more 
exposed high energy sites for ibuprofen. On the other hand, the plots of the dry coated 
ibuprofen are almost flat with surface energy values similar to those of the nano-silicas. 
These results show that by coating the surface with nano-silica, the heterogeneous 
surface of the milled ibuprofen was effectively transformed into a nearly homogeneous 
surface having properties of silica. To the authors’ knowledge, these are the first results 
where through use of surface energetics, we demonstrate that heterogeneous surfaces 
could be stabilized and passivated, and made nearly homogenous though dry coating. 
This passivation of high energy sites results in improvements in bulk powder properties 
through reduced cohesion, leading to less agglomeration and better packing enabled by 
easier particle rearrangements, as has been presented above.  
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(a) 
 
(b) 
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(c) 
 
Figure 4.9 Surface energy heterogeneity profile of ibuprofen sample for: 5 μm (a), 15 μm 
(b) and 28 μm (c) uncoated and dry coated ibuprofen powders. 
 
4.4 Conclusions 
We presented results for micronization of ibuprofen via FEM process, starting from the 
same material, and resulting in several different sizes ranging from 5 to 28 µm. All the 
bulk results showed that for pure API micronization without coating, as the particle size 
becomes smaller, the bulk properties, such as flow and bulk density deteriorate drastically. 
On the other hand, the results indicate that micronization along with dry coating with 
hydrophilic and highly hydrophobic silicas, all properties improved for all the different 
micronized sizes. XRD results for the finest micronized ibuprofen with or without dry 
coating indicated that the milling process did not induce any phase transformation, 
preserving the original crystalline nature of the drug. From these results we can conclude 
that through dry coating, typical disadvantages of micronization are mitigated.  
123 
 
 
 
Detailed surface energy measurements were done to understand micro level 
changes due to dry coating and thus explain the improvements in the bulk properties. API 
such as ibuprofen, being crystalline, was shown to have higher surface energy as it was 
made finer via milling. The results for micronized ibuprofen indicated heterogeneity of 
surface energy, which is more pronounced as size reduction increased, and thus overall 
surface energy also increased. On the other hand, dry coating with nano-silica of lower 
surface energy uniformly reduced the surface energy to a point that the surface energy of 
5 micron ibuprofen is almost the same as the original 58 micron ibuprofen when 
hydrophobic silica was used to "quench" high energy sites. This hypothesis is supported 
by the surface energy heterogeneity results that show how dry coating reduced surface 
energy heterogeneity. Analysis based on surface energy was also used to explain the 
relative dry coating performance of TS530 and M5-P silicas, agreeing with better 
dispersion of TS530 on the surface of ibuprofen. These results along with powder 
properties support previous models showing that surface modification leads to cohesion 
reduction due to the creation of nano-scale surface roughness and reduced surface energy. 
Thus simultaneous dry coating during micronization is advantageous and eliminates 
disadvantages of micronization typically faced in pharmaceutical manufacturing.  
In summary, this chapter demonstrates that detailed surface energy measurements 
can be used to examine the effect of micronization with and without surface modification 
and hence may help design improved pharmaceutical micronization strategy. Further, the 
results presented here demonstrate for the first time to our knowledge, that dry coating 
during micronization not only lowered surface energy, but it also significantly reduced 
surface energy heterogeneity. The approach presented was highly effective for ibuprofen, 
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suggesting that surface modification can almost negate the intrinsic surface energetics of 
the milled crystals, and instead, milled ibuprofen exhibited almost same energetics 
regardless of the level of size reduction.   
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CHAPTER 5 
A SIMPLE METHOD TO ESTIMATE THE GRANULAR BOND NUMBER 
5.1 Introduction 
Cohesion affects the packing properties as well as the breaking and flow of fine powders 
in a fundamental way, which are crucially important in the design of industrial storage 
and delivery devices for fine powders. Bond number, defined as the ratio of inter-particle 
force to the force of gravity, is an effective criterion to classify the flowability of powders. 
It is clarified that the cohesiveness of the powder is negligible with Bo < 1 and the 
powder can be considered as free-flowing individually; otherwise, the powder is cohesive 
and tends to agglomerate. It has been found that the flowability of cohesive powders 
decreases when the granular Bond number increases using numerical simulation and 
experiments (Nase et al. 2001). Although extensive research has been conducted on fine 
powders, it is still very difficult to control, model and measure the inter-particle force. As 
a result, Bond number is difficult to estimate. Traditional method of estimating the 
granular Bond number is via either AFM or IGC method. Both of methods are time 
consuming and expensive to operate. In this chapter, a simple and inexpensive shear test 
based method is developed to estimate the granular Bond number under no consolidation 
state by using Chen’s advanced full-off force model to back calculate the work of 
cohesion. This advanced model considers the effect of inter-particle compressive force 
and contact deformation under small consolidation. Estimated Bond numbers are 
compared and verified with those calculated from IGC method and comparable results 
can be obtained. Further, estimated Bond number is correlated with the bulk flow 
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properties. The overall effect of dry coating (changing both of the surface energy and 
nano-scale asperities) can be seen using the Bond number.  
5.2 Experimental 
5.2.1 Materials 
Ibuprofen 50 was purchased from BASF (NY, USA). Median particle size (d [v, 0.5]) is 58 
m; volume mean particle size (d [4, 3]) is 73 m. The dry coating material was 
amorphous hydrophilic nano-silica (M5-P, pharmaceutical grade, Cabot Corporation, 
MA), hydrophobic nano-silica TS530 (Cabot Corporation, MA) and R972P (AEROSIL® 
R 972 Pharma, Evonik, NJ). Pharmatose 450, Pharmatose 350 were provided from DFE 
Pharma (NJ), Sorbolac 400 and Granulac 230 were provided by Meggle Excipients and 
Technology (Germany). mAPAP was purchased from Mallinckrodt Inc. (MA); 
cornstarch was purchased from Argo. Decane, nonane, octane, hexane and heptane were 
used as probes in the IGC. All the probe solvents were HPLC grade and purchased from 
Sigma–Aldrich, USA.  
5.2.2 Preparation of Dry Coated and Uncoated Samples 
Two types of dry coated samples were prepared: micronized and dry coated samples were 
pared in the fluid energy mill (FEM) and dry coated only samples were prepared using an 
acoustic mixer. Corresponding uncoated counterparts were also prepared accordingly for 
comparison. Detailed procedure for preparing micronized and dry coated or uncoated 
samples was described in Chapter 2. The procedure of preparing dry coated only samples 
can be found from [137, 138]. In this type of dry coating, a resonant acoustic mixer 
(LabRAM, 500 g capacity, Resodyn) was used. The host and guest particles were placed 
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into plastic bottles (~ 30 g) and mixed for 5 min at a mechanical driver magnitude of 75 
times the acceleration of gravity. The mixing oscillation mixing frequency was optimized 
by the RAM driver control module to mix the powder at resonance.  
 
Table 5.1 Material Code for Ibuprofen Samples 
Material Code d10 (µm) d50 (µm) d90 (µm) 
As received 
Ibuprofen 50 
As received IBU 50 16.1 57.9 146.7 
M5P dry coated 
ibuprofen 
M5P-DC-IBU-5 1.7 5.5 11.9 
M5P-DC-IBU-10 3.5 10.9 21.5 
M5P-DC-IBU-15 3.9 15.0 29.6 
M5P-DC-IBU-20 2.7 19.1 48.2 
M5P-DC-IBU-28 5.4 26.6 67.1 
TS530 dry coated 
ibuprofen 
TS530-DC-IBU-5 1.7 6.9 14.8 
TS530-DC-IBU-10 3.3 10.6 20.4 
TS530-DC-IBU-15 6.1 14.9 29.8 
TS530-DC-IBU-20 9.2 19.8 35.5 
TS530-DC-IBU-28 9.2 28.3 74.0 
Uncoated  ibuprofen 
UC-IBU-5 1.3 4.6 9.9 
UC-IBU-10 3.0 11.7 11.9 
UC-IBU-15 6.4 14.4 28.8 
UC-IBU-20 6.0 20.7 48.2 
UC-IBU-28 7.1 27.4 69.4 
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Table 5.2 Material Code for Various Samples 
Material Code d10 
(µm) 
d50 
(µm) 
d90 
(µm) 
Span=(d90-
d10)/d50 
R972P dry coated 
mAPAP 
R972P-DC-
mAPAP 
2.98 11.2 37.6 3.1 
R972P dry coated 
cornstarch 
TS530-DC-CS 7.66 13.7 21.9 1.0 
R972P dry coated 
Sorbolac 400 
R972P-DC-
Sorbolac 400 
2.54 15.1 23.2 2.0 
TS530 dry coated 
Pharmatose 450 
TS530-DC-
pharmatose450 
3.01 16.7 44.1 2.5 
R972P dry coated 
Granulac 230 
R972P-DC-
Granulac230 
3.72 23.9 63.0 2.5 
TS530 dry coated 
Pharmatose 350 
TS530-DC-
pharmatose350 
3.42 26.0 77.9 2.9 
 
5.2.3 Powder Characterization 
5.2.3.1 Particle size measurement 
Volume based particle size distribution of powders was measured by Rodos/Helos system 
(Sympatec, NJ). Sizes representing the 10
th
, 50
th
 and 90
th
 percentile of the cumulative size 
distribution were obtained. Particle sizes were measured at dispersion pressure ranging 
from 0.2 to 2.0 bar. 
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5.2.3.2 Scanning Electron Microscope (SEM) 
The morphology of particles was examined using a Field Emission scanning electron 
microscope (FESEM) (LEO 1530 170, Carl Zeiss SMT Inc.)  All powder samples were 
pre-coated with carbon by sputter coater to enhance conductivity under FESEM. 
5.2.3.3 Powder characterization using FT4 powder rheometer 
In this work, the Freeman FT4 powder rheometer (Freeman Technology Ltd, 
Worcestershire, UK) with the shear cell module was used to measure shear stress at 
different normal stresses. Detailed descriptions for the shear test was described in 
Chapter 2 and 4.  
A Mohr’s diagram was constructed using the FT4 software and the unconfined 
yield stress was obtained from the Mohr diagram. The tensile strength of a powder can be 
regarded as the completion of the yield locus in the shear-normal stress profile. The 
negative stress, at zero shear, to break apart the consolidated particulate powder is thus 
termed the tensile strength of a powder, Figure 5.1 [68, 139, 140]. All the samples were 
test twice and average values were reported. 
 
 
Figure 5.1 Schematic illustration of obtaining isostatic tensile strength from Mohr circle. 
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5.2.4 Procedure of Estimation of the Bond Numbers  
Bond number was estimated from FT4 shear test and was also estimated using surface 
energy results from IGC measurement. Bond numbers obtained from the two methods 
were compared. 
a. Shear test method 
In order to calculate the inter-particle adhesion force at un-consolidated state using 
Chen’s advanced pull-off force model (equation 5.1), the only unknown parameter work 
of adhesion Δ needs to be obtained. As a result, the main goal of using the shear test 
based method is to calculate the interfacial surface energy. The key point of using the 
shear test based method to obtain the interfacial surface energy is to utilize the modified 
Rumpf equation, equation 5.2, [141] via procedure outlined in [142, 143].  Here, Fi is the 
inter-particle force, σi is the bulk stress, dp is the particle size and ϕ is the solid fraction in 
the powder bed. The modified Rumpf equation is the “bridge” between the bulk level 
property and the particle level property. For example, if the consolidation stress (alt. 
tensile strength) is used in σi when applying equation 5.1, Fi corresponds to the inter-
particle compressive force (alt. pull-of force). Figure 5.2 shows how the inter-particle 
pull-off force is calculated. First, tensile strength at 3 kPa and porosity are employed to 
calculate the inter-particle pull-off force at 3 kPa by using the modified Rumpf equation 
5.2. Second, consolidation stress and porosity from the shear test are employed to 
determine the inter-particle compressive force Fon between two dry coated particles by 
using modified Rumpf equation 5.2 again. Third, inputting the above two parameters, 
inter-particle pull-off force at 3 kPa and inter-particle compressive force were used in 
Chen’s advanced pull-off force model for consolidated state (equation 5.3), the only 
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unknown parameter which is the interfacial surface energy can be obtained. Finally, by 
using the DMT equation [28] for the case of Tabor parameter less than 1 [144], the inter-
particle pull-off force at un-consolidated state can be obtained.  
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Figure 5.2 Flow chart of pull-off force calculation using shear test method for dense dry 
coating samples. 
 
 
Figure 5.3 Flow chart of pull-off force calculation using shear test method for uncoated 
samples. 
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b. IGC method 
Surface energy measurements were carried out using an automated inverse gas 
chromatograph (IGC 2000, Surface Measurement Systems Ltd., Middlesex, UK) 
equipped with a flame ionization detector (FID). Compressed methane (SOS Gases, Inc) 
was used as the reference gas, helium (SOS Gases, Inc) was used as the carrier gas with 
hydrogen (SOS Gases, Inc) and compressed air employed for the FID. Detialed procedure 
was discussed in Chapter 4.  
 The bond number was estimated according to DMT model, equation 6.4. 
Surface roughness was used as the primary particle size of the nano-sized silica [145]. 
Bond number estimated from both shear test and IGC will be compared and discussed.  
5.3 Results and Discussion 
5.3.1 Examination of Proposed Method 
In this section, first the proposed method to estimate the granular Bond number is 
examined by comparing the results with those from the IGC method. After the method is 
validated, the relationship between dry coating parameters (silica coating SAC, surface 
energy, surface roughness) and the Bond number is discussed. The overall effect of dry 
coating can be observed using estimated Bond number. 
Figure 5.4 illustrates the angle of repose results for all the materials studied. In 
terms of powder flow, it is considered that the angle of repose (AOR) in the range of 30–
35° indicates excellent flowability and angle of repose less than 40° is considered to be 
acceptable (Carr, 1965). By comparing the dry coated samples with their uncoated 
counterparts, a general trend of decreasing of angle of reposes after dry coating can be 
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observed. This indicates that after dry coating, the flowability is improved for all the 
samples.  
Figure 5.5 illustrates the comparison of the Bond numbers obtained from the IGC 
method and the proposed shear test method for (a) M5P dry coated ibuprofen samples 
with 5- 28 µm in size and (b) TS530 dry coated ibuprofen samples. It can be seen from 
both of the figures that comparable Bond numbers are obtained from the two methods. In 
addition, there is a general trend of decreasing of Bond number as the particle size 
increases, indicating the powder flow is improved. This can be explained by analyzing 
the definition of Bond number, which is the ratio of inter-particle adhesion force and the 
force of gravity. According to [29, 146], for dense dry coated samples, the dominated 
inter-particle adhesion force is the van der Waals attraction between two guest particles 
and the van der Waals attraction between two host particles and host-guest particle can be 
neglected. As a result, the numerators in the Bond number formula are the same for all 
the M5P dry coated samples and the denominators increase as the particle size increases. 
Bond numbers as a function of particle size correlate well with the AOR results in Figure 
5.3.  
In addition to the ibuprofen samples with different sizes, various other materials 
are also dry coated and Bond numbers are examined to further evaluate the proposed the 
method (Figure 5.5). It can be observed again that comparable Bond numbers can be 
obtained from the two methods. If comparing the Bond numbers of both R972P dry 
coated mAPAP and cornstarch, the Bond number for dry coated cornstarch is smaller (the 
size is larger than the mAPAP). This again can be explained by analyzing the Bond 
number formula similar to ibuprofen samples. An interesting observation is from material 
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2 and 3, which are cornstarch and Sorbolac 400. The larger size Sorbolac 400 has higher 
Bond number compared to the dry coated cornstarch. This might be because of the shape 
effect. Cornstarch is more spherical in shape compared to the Sorbolac 400. The irregular 
shape of Sorbolac 400 may increase the friction between particles and cause the powder 
to be more cohesive. The effects of surface area coverage, dry coating materials with 
different surface energy and surface roughness on dry coating will be discussed in 
detailed in the next section using the estimated granular Bond number established in this 
section. 
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Figure 5.4 Angle of repose results of various materials. 
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Figure 5.5 Comparison of Bond number estimated from IGC and shear test method for 
M5P dry coated (a) and TS530 dry coated (b) milled ibuprofen samples. 
 
137 
 
 
 
1 2 3 4 5 6
B
o
n
d
 N
u
m
b
e
r 
(-
)
100
101
102
103
104
IGC
Shear Test
 
Figure 5.6 Comparison of Bond number estimated from IGC and shear test method for 
various materials. 
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Table 5.3 Material Information for Various Samples in Figure 5.6 
 
 
 
 
 
 
 
 
5.3.2 Analysis the Effects of Dry Coating Using Bond Number 
It is known that several guest material properties (surface energy, surface roughness and 
amount of silica or SAC) have effect on the overall powder flow improvement. In section 
5.3.1, the proposed method is examined by comparing the Bond numbers with those from 
IGC method. In this section, the proposed method will be used to analyze the effects of 
guest material properties on flow improvement. Two types of material (milled ibuprofen 
and mAPAP) were dry coated with different SAC% and analyzed.  
Figure 5.7 illustrates the bulk properties of both milled ibuprofen and mAPAP 
powders with different SAC% silica coating. Two bulk properties are analyzed: porosity 
and unconfined yield strength (UYS). Porosity (or bulk density) is considered as one of 
the critical properties in handling, storage and processing powders, where lower values 
typically indicate better packing and flow [85]. And the unconfined yield strength (UYS) 
 Material 
Dry coating 
material 
Median 
Particle 
Size (µm) 
1 mAPAP R972P 11.2 
2 Cornstarch R972P 13.7 
3 Sorbolac 400 R972P 15.1 
4 Pharmatose 450 TS530 16.7 
5 Granulac 230 R972P 23.9 
6 Pharmatose 350 TS530 26.0 
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is the compressive strength or cohesive strength of the powder [57, 59], which is caused 
by the cohesive forces acting between the particles. The UYS is an important parameter 
regarding the powder flow (i.e., the most important parameter relating to prediction of the 
arching and minimum hopper outlet) [59]. With these in mind, the porosities and UYS of 
two types of powders have been characterized. According to Molerus [124], the UYS is 
proportional to the cohesive force (at unconsolidated state) and inversely proportional to 
the square of the particle size (equation 1), hence, it is a direct measure of the cohesive 
nature of the particles. As it can be seen, there is a general trend of decrease of porosity 
and UYS with increasing of SAC%. There is a substantial difference in powder flow 
between uncoated sample (with 0% SAC) and 100% SAC dry coated sample: from the 
figure, it can be seen that the UYS of the 100% SAC dry coated samples are about 5 
times less than their uncoated counterparts and the porosity is about 30% less; similarly, 
the UYS is 6.9 times less and porosity is 17% less for dry coated mAPAP. UYS can give 
direct indication of the inter-particle adhesion as per equation 1. Accordingly, for samples 
having the same particle size, the dry coated samples have significantly lower inter-
particle cohesion than the uncoated counterparts. This indicates that dry coating improves 
the bulk powder flowability. In addition, taking a close analysis of the plot, three 
distinguished regions with two plateaus can be observed. This can be explained by the 
adhesion forces between particles with different types of contact model (Figure 5.8) and 
will be further explained later.  
 
2
adFUYS
d
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The force of attraction between two surfaces is primarily a function of their 
material property, such as surface energy or Hamaker constant and contact radius [29, 35, 
36], and dry coating of nano-silica is expected to influence both. Dry coating of nano-
silica can reduce the surface roughness to about the same order magnitude of the diameter 
of the nano-silica [145, 146].  And dry coating can also modify the surface energy as 
discussed in Chapter 4. Figure 5.9 illustrates the dispersive surface energy as a function 
of SAC%. Interestingly, for milled ibuprofen, there is a general trend of decrease of 
dispersive surface energy as increasing of SAC% and a plateau can be reached at SAC% 
of 30%. It needs to point out that the material studied is micronized ibuprofen via FEM 
process (described in Chapter 2). It has been shown in Chapter 4 that micronization 
process can expose higher surface energy sites on the particle surface, leading to stronger 
inter-particulate cohesion. And dry coating can cover these high surface energy sites 
leading to reduced surface energy and cohesion. On the other hand, mAPAP was used as 
received to perform dry coating only and there is no micronization process involved. For 
the case of mAPAP (Figure 5.9 b), dry coating does not change the surface energy. This 
might be because of the different interaction between different drug surfaces and the 
silica. It can be seen from Figure 5.9 that depending on the dry coating process and host 
materials, the surface energy change due to dry coating is different. It is process and 
material dependent. 
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Figure 5.7 Bulk properties of milled ibuprofen (a) and mAPAP (b) with various SAC%. 
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   (a)                                           (b)                                   (c) 
 
Figure 5.8 Contacts between two dry coated particles depending on different SAC (a) 
host-host contact, (b) guest-host contact and (c) guest-guest contact. image from [147]. 
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Figure 5.9 Dispersive surface energy of milled ibuprofen (a) and mAPAP (b) with 
various SAC% . 
 
   As motioned, dry coating can influence both of the surface roughness and surface 
energy. The combined effect of dry coating of nano-silica on the powder flow can now be 
analyzed using the Bond number. Figure 5.10 shows the Bond number estimated from 
both IGC method and proposed shear test method for ibuprofen samples with different 
SAC%. It can be seen from both methods that there is a significant reduction of Bond 
number comparing the uncoated sample (0% SAC) with the 100% SAC dry coated 
sample. Comparing the Bond number with the bulk flow properties in Figure 5.7, the 
Bond number from the proposed method seem to give a better correlation. Similar to the 
trend of bulk properties plot, three regions and two plateaus can be observed. For dry 
coated ibuprofen (SAC% greater than 0%), the guest particles are expected to cover on 
the ibuprofen surface (both covering the high energy sites and creating the nano-scale 
roughness), and the cohesion properties will be reduced and when there is a sufficient 
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surface area coverage, the cohesion will be defined by the nano-silica (guest-guest 
contact) and not the micronized ibuprofen [29, 36]. Chen proposed there are three types 
of contact for dry coated powders depending on the SAC% : host-host contact, host-guest 
contact and guest –guest contact, Figure 5.8. Accordingly, the critical SAC% of the 
transition from host-host to host-guest is SAC of 4.4% and from host-guest to guest-guest 
is SAC of about 30%, which coincides with the present experimental data in Figure 5.10 
and Figure 5.11 [29, 36]. From both figures, it can be seen that Bond numbers drop from 
host-host contact to host-guest contact and decrease again at SAC of 30% and eventually 
reach a plateau.   
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Figure 5.10 Bond number estimated from IGC method (a) and shear test method (b) 
for milled ibuprofen samples with different SAC%. 
 
Figure 5.12 summarizes the bulk flow properties with estimated Bond number 
from the proposed method. As it can been seen, there is a good correlation between bulk 
powder flow properties (porosity and UYS) and Bond number: as the Bond number 
decreases, the powder flow properties are improved. Especially, when the SAC is beyond 
30%, the Bond numbers are almost the same and the flow properties are also about the 
same (scattering in the left lower region). This supports the pervious finding that over 
certain amount of silica coating, the flow improvement will reach a plateau and this is 
because fo the dominated adhesion force between two dry coated particles are dominated 
by the nano-silica on the surface. Further increasing the amount of silica, does not change 
the adhesion force. As a result, the Bond numbers stay almost the same and the powder 
flow properties stay almost the same. Interestingly, it can be observed that, for 100%  
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SAC dry coated ibuprofen and mAPAP powders, although mAPAP has relatively lower 
Bond number (300 for ibuprofen and 200 for mAPAP), dry coated ibuprofen has 
relatively better bulk powder flow properties. This might be because of the shape effect. 
As shown in Figure 5.13, ibuprofen is more spherical and mAPAP is rod shape; the rod 
shape is expected to increase friction and inter-locking between particles. It is known that 
shape has an important effect on porosity. The shape effect shape of mAPAP is believed 
to contribute to difference in powder flow properties observed. 
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Figure 5.11 Bond number estimated from IGC (a) and shear test (b) for mAPAP with 
various SAC%. 
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Figure 5.12 Bond number vs. bulk flow properties for mIBU and mAPAP samples 
with various SAC%. 
 
(a) 
 
Figure 5.13 SEM images of 100% SAC dry coated ibuprofen (a-b) and mAPAP (c-d), 
continued. 
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(b) 
 
 (c) 
 
Figure 5.13 SEM images of 100% SAC dry coated ibuprofen (a-b) and mAPAP (c-d), 
continued. 
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(d) 
 
Figure 5.13 SEM images of 100% SAC dry coated ibuprofen (a-b) and mAPAP (c-d), 
continued. 
  
5.4 Conclusions 
In this chapter, Bond number, as an effective criterion to classify the flowability of 
powders was estimated through a proposed shear test based method. Estimated Bond 
numbers are compared and verified with those calculated from the IGC method and 
comparable results were obtained. Further, estimated Bond number was correlated with 
the bulk flow properties. The overall effect of dry coating (changing both of the surface 
energy and nano-scale asperities) can be seen using the Bond number. This chapter 
highlighted the usefulness of the proposed method to predict bulk powder flow properties 
using the Bond number.  
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CHAPTER 6 
SUMMARY 
 
The research presented in this dissertation has focused on the implementation of particle 
engineering via surface modification during micronization process for pharmaceutical 
application. The dissertation focused on establishing the main hypothesis: simultaneous 
micronization and dry coating process (SM-DC) would be beneficial for pharmaceutical 
application. In order to address this, several topics were investigated and main questions 
outlined in Chapter 1 were answered.  
In Chapter 2, using ibuprofen as a test-case, it is showed that flow properties and 
dissolution rate were significantly improved when micronization was performed along 
with dry coating (SM-DC process). Additionally, co-grinding with water-soluble polymer 
during micronization was considered and led to further dissolution rate improvement and 
increased bulk density. The surface modified, micronized powders also showed improved 
dispersion, significantly higher bulk densities, reduced electrostatic charging, and higher 
flowability compared to the pure micronized sample. Next, in Chapter 3, these dry coated 
fine API powders were formulated into blends with different drug loadings. The results 
showed that the blends containing dry coated API powders, even micronized ones, had 
excellent flowability and high bulk density. In contrast, blends containing uncoated APIs 
had poor flow and lower bulk densities. As the drug loading increased, the difference 
between dry coated and uncoated blends was more pronounced, which was clearly 
illustrated through a bulk density-FFC (flow function coefficient) phase map. Tablets 
prepared from dry coated API blends exhibited superior compactibility and dissolution 
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profiles, particularly for higher drug loadings. This illustrated the advantages of the dry 
coating during API micronization, without any adverse impact on tabletting operations 
and tablet properties. Next, in Chapter 4 an in-depth understanding of the effect of 
milling and dry coating on the surface properties of milled ibuprofen powders was 
investigated. Inverse Gas Chromatography (IGC) technique was used and it was shown 
that the dispersive surface energy of pure milled powders is heterogeneous in nature. In 
contrast, dry coating with nano-particles was found to quench the high energy sites and 
make the surface energy of the powders comparatively uniform and the average values 
similar to that of the nano-particle used for the dry coating. Last, in Chapter 5), a simple 
shear test based method was developed to estimate the granular Bond number to evaluate 
the performance of dry coating. This technique is very important for industry because it 
eliminates the usual need of detailed, time consuming particle scale characterization via 
atomic force microscopy (AFM), which would be otherwise necessary. Estimated Bond 
numbers were compared and verified with those calculated from IGC method. Further, 
estimated Bond number was correlated with the bulk flow properties. The overall effect 
of dry coating (changing both the surface energy and nano-scale asperities) can be well 
demonstrated using the estimated Bond numbers. By addressing these four issues, the 
main hypothesis of the thesis, dry coating applied to the micronization process is 
beneficial to the pharmaceutical application, is proven. Major accomplishments of the 
dissertation are: 
 Surface properties, e.g., surface energy and surface roughness of fine cohesive 
particles are successfully modified by utilizing fluid energy milling based novel 
dry particle coating technique to reduce the particle cohesion. 
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 It is shown that reduced cohesion via surface modification during milling process 
improves the properties of milled powders, such as powder flow, reduced 
electrostatic charging, improved bulk density and improved dissolution rate. 
 
 A fundamental understanding of the effect of dry coating during milling process is 
developed.  
 Developed a time and cost saving method to estimate the granular Bond number. 
Predicted results agree with those from IGC measurements and more importantly 
correlate well with the bulk powder flow properties, indicating that it is promising 
to predict the bulk behavior of fine particles using predicted granular Bond 
number. 
 
Suggested future work based on the results of this thesis are:  
1. It is suggested that in addition to ibuprofen, multiple other APIs can be used 
to further test the SM-DC process. 
 
2. Additive materials such as hydrophobic biocompatible materials such as 
eudragit, amino acid, biosurfactants and MgSt should be investigated. The 
mechanisms of cohesion reduction of using such materials in contrast to using 
discrete nano-particles should be investigated. Ultimately, the most 
challenging aspect would be to find an equivalent of silanization 
process/materials that are suitable for pharmaceutical and food applications.  
 
3. It is also suggested to further investigate the applicability of surface energy 
characterization tools such as inverse gas chromatography for the analysis of 
binary systems.   
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APPENDIX A 
TRANSFER PHENOMENA FOR BINARY HOST PARTICLES SYSTEM 
A.1 Introduction 
Binary mixture of host particles is an interesting research area and there is very little 
reported study on this. Especially it is more relevant for real pharmaceutical applications. 
For example, usually more than one component exist in a pharmaceutical powder system.  
It would be interesting and useful to study whether there is guest particle transfer from 
one type of host particle surface to the other. 
A.2 Experimental 
A.2.1 Materials 
Cornstarch (Argo, USA) and Alumina (Altanic equipment engineers, A Division of 
Micron Metals, Inc.) were used as host particles. Aerosil R972P (Evonik, USA) was used 
as guest particle. 
A.2.2 Dry Coating and Mixing Procedure 
Dry coating was performed using an acoustic mixer, LabRam (Ram, Resodyn 
Corporation, USA). Detailed procedure was described in Chapter 5, section 5.2.2. The 
amount of nano-silica used was based on the 50% surface area coverage (SAC) according 
to [31]. Two types of mixing devices were used in order to mix the binary powders at 
both high and low intensity. Low intensity mixing was performed using a V-blender 
(mixing time 5 min). High intensity mixing was performed using the LabRam again (75G 
and 5 min). Four experiments were performed and listed in Table A.1.  
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Table A.1. Experimental list 
Exp# Host 1 Host 2 Guest Mixing device 
1 
As received 
Cornstarch 
As recvived 
Aluminum 
Silica 
R972P 
LabRam 75G 5min 2 
Dry coated 
Cornstarch 
As received 
Aluminum 
- 
3 
As received 
Cornstarch 
Dry coated 
Aluminum 
- 
4 
As received 
Cornstarch 
Dry coated 
Aluminum 
- V-blender 5min 
 
A.2.3 Scanning Electron Microscope (SEM) 
The morphology of the host particles was examined using a Field Emission scanning 
electron microscope (FESEM) (LEO 1530 170, Carl Zeiss SMT Inc.)  All powder 
samples were pre-coated with carbon by sputter coater to enhance conductivity under 
FESEM. 
A.2.4 Particle Size Measurement 
Volume based particle size distribution of powders was measured by Rodos/Helos system 
(Sympatec, NJ). Sizes representing the 10
th
, 50
th
 and 90
th
 percentile of the cumulative size 
distribution were obtained. Particle sizes were measured at dispersion pressure ranging of 
0.5 bar. 
A.2.5 Surface Energy Measurement 
Surface energy of each material were measured using an inverse gas chromatography 
(IGC). Detailed procedure of IGC surface energy measurement was described in Chapter 
4, section 4.2.3. 
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A.3 Results and Discussions 
Material properties of both hosts and guest particles are listed in Table A.2. It can be seen 
that both of the host particles have similar sizes with Aluminum having a slightly larger 
size. From the literature, it is suggested that reduced spreading coefficient can be used to 
predict the coating quality (equation A.1). In the equation, 
B/Aλr denotes the spreading 
coefficient of material B onto material A; γd is the dispersive surface energy, γp is the 
polar surface energy and 
Bγ is the total surface energy of material B. According to Rowe 
[109], complete spreading will occur when λ ≥ 1. As a result, reduced spreading 
coefficients for both pairs of host-guest are calculated based on the surface energy via 
IGC measurement (Table A.3). Both of the values are greater than 1, indicating that guest 
particle silica R972P will be completely coated onto both of the host particle surfaces. In 
addition, reduced spreading coefficient for silica-Aluminum pair is greater than the silica-
cornstarch pair. This indicates that, based on the reduced spreading coefficient, silica 
particles preferentially coat Aluminum surface. 
Results of experiemnt1-4 based on SEM images are shown in Figure A.1-4.From 
Figure A.1 it can be seen that under high intensity mixing (LabRam mixing), silica 
particles actually preferentially coat cornstarch surface, which is contradictory to what it 
is expected according to the reduced spreading coefficient. Figure A.2 and A.3 further 
confirm this: when cornstarch was coated first, most of the silica particles stay onto the 
cornstarch surface; when Aluminum was coated first, most of the silica particles transfer 
from Aluminum surface to cornstarch surface after high intensity mixing. Figure A.4 
shows mixing results under low intensity mixing (V-blender mixing). Under low intensity 
mixing, it can be observed that silica stay onto the Aluminum surface and there is no 
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transfer phenomenon. Figure A.5 summarizes the experimental observation from the 
SEM images. From the experimental results, it can be concluded that reduced spreading 
coefficient cannot be used to explain the results; mixing intensity matters, transfer of 
guest particle only occurs under high intensity mixing.  
 It is hypothesized that the transfer phenomenon of guest particles from one type of 
surface to the other is because of the change of adhesion force between silica-aluminum 
and silica –cornstarch under different mixing intensity. Reduced spreading coefficient is 
similar to the ratio of work of adhesion to work to cohesion. However, this approach has 
some limitations. It only takes into account of material property such as surface energy. It 
does not take into account of other factors that can also influence the adhesion, such as 
inter-particle compressive force, material hardness and contact area, as discussed in 
Chapter 1, section 1.4. Form Table A.2, it can be seen that Aluminum and cornstarch has 
very different material hardness. Under high intensity mixing, two types of host particles 
will have different degree of contact area deformation. It is expected that cornstarch will 
have much larger contract area deformation because of the much softer material property 
compared to the Aluminum.  
 To qualitatively explain the experimental results, Chen advanced model is used. Chen 
advanced model was discussed in Chapter 1, section1.4. In Chen advanced model [28], 
the effect of inter-particle compressive force and contact area deformation under 
consolidation are taken into account. Figure A.6 illustrates the tow pairs of the adhesion 
force as a function of the inter-particle compressive force. Both of the adhesion forces 
increase as the inter-particle compressive force increases. However, under high intensity 
mixing (high inter-particle compressive force), the adhesion force between cornstarch 
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and silica increases to a much greater extend compared to the other pair of adhesion force. 
Chen advanced model, helps to explain the adhesion force change under different mixing 
intensity. Now the experimental results can be explained. Under high mixing intensity, 
transfer phenomenon occurs because of the stronger adhesion force between cornstarch 
and silica. In contrast, under low mixing intensity, the two pairs of the adhesion forces 
are about the same, resulting no transfer phenomenon.  
   
Table A.2 Material properties of hosts and guest particles 
 d50(µm)  True 
Density 
(g/ml)  
Young’s 
Modulus 
(GPa) * 
Poisson 
Ratio * 
Hardness 
(Gpa) * 
Dispersive 
Surface 
Energy 
(mJ/m
2
)  
Polar 
Surface 
Energy 
(mJ/m
2
) 
Aluminum  20.1  2.70  69  0.22  11.8  60.3  16  
Cornstarch  15.0  1.55  9.4  0.33  0.93  45.4  6.2  
R972P  0.016  2.2  74  0.17  6  34.0  5.8  
Source: [151] 
  
 /
2
( ) ( )
A BA B
p pB A d d
r B A B A B
d d p p
  

    
 
  
   
 (A.1) 
 
Table A.3 Calculated reduced spreading coefficient based on surface energy 
Host Particle 
Guest 
Particle 
reduced spreading 
coefficient 
Aluminum 
R972P 
Silica/Al
 λ=1.3 
Silica/CS
 λ=1.1 
Cornstarch 
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Figure A.1 SEM images of experiment 1. 
 
Figure A.2 SEM images of experiment 2. 
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Figure A.3 SEM images of experiment 3. 
. 
Figure A.4 SEM images of experiment 4. 
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Figure A.5 Summary of Experiment 1-4 observations from SEM images.  
 
 
Figure A.6 Adhesion calculated based on Chen model as a function of compressive force. 
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A.4 Conclusions 
A binary mixture system was studied. The example indicated that mixing impacts the 
material microstructure, depending on the intensity of mixing as well as the property of 
the materials.  Both of them affect the adhesion force between guest and host particle. 
Chen advanced model, taking into account of both properties, was able to explain the 
experimental results.  
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